{"parse":{"title":"Tumor microenvironment","pageid":38925137,"revid":855917314,"text":{"*":"<div class=\"mw-parser-output\"><p>The <b>tumor microenvironment</b> (TME) is the cellular environment in which the tumor exists, including surrounding blood vessels, immune cells, <a href=\"/wiki/Fibroblast\" title=\"Fibroblast\">fibroblasts</a>, bone marrow-derived inflammatory cells, lymphocytes, signaling molecules and the <a href=\"/wiki/Extracellular_matrix\" title=\"Extracellular matrix\">extracellular matrix</a> (ECM).<sup id=\"cite_ref-1\" class=\"reference\"><a href=\"#cite_note-1\">&#91;1&#93;</a></sup>\n<sup id=\"cite_ref-:0_2-0\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n<sup id=\"cite_ref-physicalMicroenvironment_3-0\" class=\"reference\"><a href=\"#cite_note-physicalMicroenvironment-3\">&#91;3&#93;</a></sup> The tumor and the surrounding microenvironment are closely related and interact constantly. Tumors can influence the microenvironment by releasing extracellular signals, promoting <a href=\"/wiki/Angiogenesis#Tumor_angiogenesis\" title=\"Angiogenesis\">tumor angiogenesis</a> and inducing <a href=\"/wiki/Immune_tolerance#Peripheral_tolerance\" title=\"Immune tolerance\">peripheral immune tolerance</a>, while the immune cells in the microenvironment can affect the growth and evolution of cancerous cells.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>\n</p><p>The tumor microenvironment contributes to <a href=\"/wiki/Tumour_heterogeneity\" title=\"Tumour heterogeneity\">tumour heterogeneity</a>.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#History\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">History</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Vasculature\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Vasculature</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-3\"><a href=\"#Enhanced_permeability_and_retention_effect\"><span class=\"tocnumber\">2.1</span> <span class=\"toctext\">Enhanced permeability and retention effect</span></a></li>\n<li class=\"toclevel-2 tocsection-4\"><a href=\"#Hypoxia\"><span class=\"tocnumber\">2.2</span> <span class=\"toctext\">Hypoxia</span></a></li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#Reactive_stromal_cells\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Reactive stromal cells</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-6\"><a href=\"#Carcinoma_associated_fibroblasts\"><span class=\"tocnumber\">3.1</span> <span class=\"toctext\">Carcinoma associated fibroblasts</span></a></li>\n<li class=\"toclevel-2 tocsection-7\"><a href=\"#Myeloid-derived_suppressor_cells_and_tumor_associated_macrophages\"><span class=\"tocnumber\">3.2</span> <span class=\"toctext\">Myeloid-derived suppressor cells and tumor associated macrophages</span></a></li>\n<li class=\"toclevel-2 tocsection-8\"><a href=\"#Neutrophils\"><span class=\"tocnumber\">3.3</span> <span class=\"toctext\">Neutrophils</span></a></li>\n<li class=\"toclevel-2 tocsection-9\"><a href=\"#Tumor_infiltrating_lymphocytes\"><span class=\"tocnumber\">3.4</span> <span class=\"toctext\">Tumor infiltrating lymphocytes</span></a></li>\n<li class=\"toclevel-2 tocsection-10\"><a href=\"#Extracellular_matrix_remodeling\"><span class=\"tocnumber\">3.5</span> <span class=\"toctext\">Extracellular matrix remodeling</span></a></li>\n<li class=\"toclevel-2 tocsection-11\"><a href=\"#Relation_to_T_cells\"><span class=\"tocnumber\">3.6</span> <span class=\"toctext\">Relation to T cells</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-12\"><a href=\"#Reproduction\"><span class=\"tocnumber\">3.6.1</span> <span class=\"toctext\">Reproduction</span></a></li>\n<li class=\"toclevel-3 tocsection-13\"><a href=\"#Apoptosis\"><span class=\"tocnumber\">3.6.2</span> <span class=\"toctext\">Apoptosis</span></a></li>\n<li class=\"toclevel-3 tocsection-14\"><a href=\"#TAMs_and_MDSCs\"><span class=\"tocnumber\">3.6.3</span> <span class=\"toctext\">TAMs and MDSCs</span></a></li>\n<li class=\"toclevel-3 tocsection-15\"><a href=\"#Spatial_distribution\"><span class=\"tocnumber\">3.6.4</span> <span class=\"toctext\">Spatial distribution</span></a></li>\n</ul>\n</li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-16\"><a href=\"#Clinical_implications\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">Clinical implications</span></a>\n<ul>\n<li class=\"toclevel-2 tocsection-17\"><a href=\"#Drug_development\"><span class=\"tocnumber\">4.1</span> <span class=\"toctext\">Drug development</span></a></li>\n<li class=\"toclevel-2 tocsection-18\"><a href=\"#Therapies\"><span class=\"tocnumber\">4.2</span> <span class=\"toctext\">Therapies</span></a>\n<ul>\n<li class=\"toclevel-3 tocsection-19\"><a href=\"#Antibodies\"><span class=\"tocnumber\">4.2.1</span> <span class=\"toctext\">Antibodies</span></a></li>\n<li class=\"toclevel-3 tocsection-20\"><a href=\"#Kinase_inhibitors\"><span class=\"tocnumber\">4.2.2</span> <span class=\"toctext\">Kinase inhibitors</span></a></li>\n<li class=\"toclevel-3 tocsection-21\"><a href=\"#Liposomes\"><span class=\"tocnumber\">4.2.3</span> <span class=\"toctext\">Liposomes</span></a></li>\n</ul>\n</li>\n</ul>\n</li>\n<li class=\"toclevel-1 tocsection-22\"><a href=\"#See_also\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-23\"><a href=\"#References\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"History\">History</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=1\" title=\"Edit section: History\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The importance of a <a href=\"/wiki/Stromal_cell\" title=\"Stromal cell\">stromal</a> microenvironment, especially \u201cwound\u201d or regenerating tissue, has been recognized since the late 1800s. The interplay between the tumor and its microenvironment was part of <a href=\"/wiki/Stephen_Paget\" title=\"Stephen Paget\">Stephen Paget</a>'s 1889 \"seed and soil\" theory, in which he postulated that metastases of a particular type of cancer (\"the seed\") often metastasizes to certain sites (\"the soil\") based on the similarity of the original and secondary tumor sites.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>\n</p><p>Its role in blunting an immune attack awaited the discovery of adaptive cellular immunity. In 1960, Klein and colleagues found that in mice, primary <a href=\"/wiki/Methylcholanthrene\" title=\"Methylcholanthrene\">methylcholanthrene</a>-induced <a href=\"/wiki/Sarcomas\" class=\"mw-redirect\" title=\"Sarcomas\">sarcomas</a> exhibited an antitumor immune response mediated by <a href=\"/wiki/Lymph_node\" title=\"Lymph node\">lymph node</a> cells to cancer cells derived from the primary tumor. This immune response did not however affect the primary tumor. The primary tumor instead established a microenvironment that is functionally analogous to that of certain normal tissues, such as the eye.<sup id=\"cite_ref-:0_2-1\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p><p>Later, mice experiments by Halachmi and Witz showed that for the same cancer cell line, greater tumorigenicity was evident <i>in vivo</i> than the same strain inoculated <i>in vitro</i>.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-Witz_7-0\" class=\"reference\"><a href=\"#cite_note-Witz-7\">&#91;7&#93;</a></sup>\n</p><p>Unambiguous evidence for the inability in humans of a systemic <a href=\"/wiki/Immune_response\" title=\"Immune response\">immune response</a> to eliminate immunogenic cancer cells was provided by Boon\u2019s 1991 studies of <a href=\"/wiki/Antigens\" class=\"mw-redirect\" title=\"Antigens\">antigens</a> that elicit specific <a href=\"/wiki/CD8%2B\" class=\"mw-redirect\" title=\"CD8+\">CD8<sup>+</sup></a> <a href=\"/wiki/T_cell\" title=\"T cell\">T cell</a> responses in <a href=\"/wiki/Melanoma\" title=\"Melanoma\">melanoma</a> patients. One such antigen was <a href=\"/wiki/Cancer/testis_antigens\" title=\"Cancer/testis antigens\">MAGE-A1</a>. The coexistence of a progressing melanoma with melanoma-specific T cells implicitly does not involve <a href=\"/wiki/Immunoediting\" title=\"Immunoediting\">immunoediting</a>, but does not exclude the possibility of TME immune suppression.<sup id=\"cite_ref-:0_2-2\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p><p>The discovery of melanoma-specific T cells in patients led to the strategy of adoptively transferring large numbers of <i>in vitro-</i>expanded <a href=\"/wiki/Tumor-infiltrating_lymphocytes\" title=\"Tumor-infiltrating lymphocytes\">tumor-infiltrating lymphocytes</a> (TILs) which has proven that the <a href=\"/wiki/Immune_system\" title=\"Immune system\">immune system</a> has the potential to control cancer. However, <a href=\"/wiki/Adoptive_cell_transfer\" title=\"Adoptive cell transfer\">adoptive T cell therapy</a> (ACT) with TILs has not had the dramatic success of ACT with virus-specific CD8<sup>+</sup> T cells. The TME of solid cancers appears to be fundamentally different to that of the <a href=\"/wiki/Leukemias\" class=\"mw-redirect\" title=\"Leukemias\">leukemias</a>, in which clinical ACT trials with <a href=\"/wiki/Chimeric_antigen_receptor\" title=\"Chimeric antigen receptor\">chimeric antigen receptor</a> T cells have demonstrated efficacy.<sup id=\"cite_ref-:0_2-3\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Vasculature\">Vasculature</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=2\" title=\"Edit section: Vasculature\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><i>See:</i> <a href=\"/wiki/Tumor-associated_endothelial_cells\" class=\"mw-redirect\" title=\"Tumor-associated endothelial cells\">Tumor-associated endothelial cells</a>\n</p><p>80\u201390% of cancer are <a href=\"/wiki/Carcinoma\" title=\"Carcinoma\">carcinomas</a>, or cancers that form in the epithelial tissue.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup> This tissue is not vascularized, which prevents tumors from growing greater than 2mm in diameter without inducing new blood vessels.<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> The process of <a href=\"/wiki/Angiogenesis\" title=\"Angiogenesis\">angiogenesis</a> is dysregulated to feed the cancer cells and as a result the vasculature formed differs from that of normal tissue.\n</p>\n<h3><span class=\"mw-headline\" id=\"Enhanced_permeability_and_retention_effect\">Enhanced permeability and retention effect</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=3\" title=\"Edit section: Enhanced permeability and retention effect\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The <a href=\"/wiki/Enhanced_permeability_and_retention_effect\" title=\"Enhanced permeability and retention effect\">enhanced permeability and retention effect</a> (EPR effect) is the observation that the vasculature of tumors is often leaky and accumulates molecules in the blood stream to a greater extent than in normal tissue. This inflammation effect is not only seen in tumors, but in hypoxic areas of <a href=\"/wiki/Myocardium\" class=\"mw-redirect\" title=\"Myocardium\">cardiac muscles</a> following a <a href=\"/wiki/Myocardial_infarction\" title=\"Myocardial infarction\">myocardial infarction</a> (MI or heart attack).<sup id=\"cite_ref-10\" class=\"reference\"><a href=\"#cite_note-10\">&#91;10&#93;</a></sup><sup id=\"cite_ref-Danhier_11-0\" class=\"reference\"><a href=\"#cite_note-Danhier-11\">&#91;11&#93;</a></sup> This leaky vasculature is thought to have several causes, including insufficient <a href=\"/wiki/Pericytes\" class=\"mw-redirect\" title=\"Pericytes\">pericytes</a> and a malformed <a href=\"/wiki/Basement_membrane\" title=\"Basement membrane\">basement membrane</a>.<sup id=\"cite_ref-Danhier_11-1\" class=\"reference\"><a href=\"#cite_note-Danhier-11\">&#91;11&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Hypoxia\">Hypoxia</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=4\" title=\"Edit section: Hypoxia\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>The tumor microenvironment is often <a href=\"/wiki/Tumor_hypoxia\" title=\"Tumor hypoxia\">hypoxic</a>. As the tumor mass increases, the interior of the tumor grows farther away from existing blood supply. While angiogenesis can reduce this effect, the <a href=\"/wiki/Partial_pressure\" title=\"Partial pressure\">partial pressure</a> of oxygen is below 5&#160;mm <a href=\"/wiki/Mercury_(element)\" title=\"Mercury (element)\">Hg</a> (venous blood has a partial pressure of oxygen at 40&#160;mm Hg) in more than 50% of locally advanced solid tumors.<sup id=\"cite_ref-Weber_12-0\" class=\"reference\"><a href=\"#cite_note-Weber-12\">&#91;12&#93;</a></sup><sup id=\"cite_ref-dx_13-0\" class=\"reference\"><a href=\"#cite_note-dx-13\">&#91;13&#93;</a></sup> The hypoxic environment leads to <a href=\"/wiki/Genome_instability#Genome_instability_in_cancer\" title=\"Genome instability\">genetic instability</a>, which is associated with cancer progression, via downregulating <a href=\"/wiki/DNA_repair\" title=\"DNA repair\">DNA repair</a> mechanisms such as <a href=\"/wiki/Nucleotide_excision_repair\" title=\"Nucleotide excision repair\">nucleotide excision repair</a> (NER) and <a href=\"/wiki/DNA_mismatch_repair\" title=\"DNA mismatch repair\">mismatch repair</a> (MMR) pathways.<sup id=\"cite_ref-14\" class=\"reference\"><a href=\"#cite_note-14\">&#91;14&#93;</a></sup> Hypoxia also causes the upregulation of <a href=\"/wiki/HIF1A\" title=\"HIF1A\">hypoxia-inducible factor 1 alpha</a> (HIF1-\u03b1), which induces angiogenesis and is associated with poorer prognosis and the activation of genes associated with metastasis,<sup id=\"cite_ref-dx_13-1\" class=\"reference\"><a href=\"#cite_note-dx-13\">&#91;13&#93;</a></sup> leading, for instance, to increased cell migration and also ECM remodeling.<sup id=\"cite_ref-physicalMicroenvironment_3-1\" class=\"reference\"><a href=\"#cite_note-physicalMicroenvironment-3\">&#91;3&#93;</a></sup>\n</p><p>While a lack of oxygen can cause glycolytic behavior in cells, tumor cells also undergo aerobic glycolysis, in which they preferentially produce <a href=\"/wiki/Lactic_acid\" title=\"Lactic acid\">lactate</a> from glucose even given abundant oxygen, called the <a href=\"/wiki/Warburg_effect\" title=\"Warburg effect\">Warburg effect</a>.<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> No matter the cause, this leaves the extracellular microenvironment acidic (pH 6.5\u20136.9), while the cancer cells themselves are able to remain neutral (ph 7.2\u20137.4). It has been shown that this induces greater cell migration <i>in vivo</i> and <i>in vitro</i>, possibly by promoting degradation of the ECM.<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup><sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Reactive_stromal_cells\">Reactive stromal cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=5\" title=\"Edit section: Reactive stromal cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>The <a href=\"/wiki/Stroma_(animal_tissue)\" class=\"mw-redirect\" title=\"Stroma (animal tissue)\">stroma</a> of a carcinoma is the connective tissue below the basal <a href=\"/wiki/Basal_lamina\" title=\"Basal lamina\">lamina</a>.  This includes <a href=\"/wiki/Fibroblasts\" class=\"mw-redirect\" title=\"Fibroblasts\">fibroblasts</a>, ECM, immune cells and other cells and molecules. The stroma surrounding a tumor often reacts to intrusion via inflammation, similar to how it might respond to a <a href=\"/wiki/Wound_healing\" title=\"Wound healing\">wound</a>.<sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup> <a href=\"/wiki/Inflammation#Cancer\" title=\"Inflammation\">Inflammation</a> can encourage angiogenesis, speed the cell cycle and prevent cell death, all of which augments tumor growth.<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Carcinoma_associated_fibroblasts\">Carcinoma associated fibroblasts</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=6\" title=\"Edit section: Carcinoma associated fibroblasts\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Cancer-associated_fibroblasts\" class=\"mw-redirect\" title=\"Cancer-associated fibroblasts\">Carcinoma associated fibroblasts</a> (CAFs) are a heterogenous group of fibroblasts whose function is pirated by cancer cells and redirected toward carcinogenesis<sup id=\"cite_ref-Hanahan_20-0\" class=\"reference\"><a href=\"#cite_note-Hanahan-20\">&#91;20&#93;</a></sup> These cells are usually derived from the normal fibroblasts in the surrounding stroma but can also come from <a href=\"/wiki/Pericyte\" title=\"Pericyte\">pericytes</a>, smooth muscle cells, <a href=\"/wiki/Fibrocyte\" title=\"Fibrocyte\">fibrocytes</a>, <a href=\"/wiki/Mesenchymal_stem_cells\" class=\"mw-redirect\" title=\"Mesenchymal stem cells\">mesenchymal stem cells</a> (MSCs, often derived from bone marrow), or via <a href=\"/wiki/Epithelial-mesenchymal_transition\" class=\"mw-redirect\" title=\"Epithelial-mesenchymal transition\">epithelial-mesenchymal transition</a> (EMT) or endothelial-mesenchymal transition (EndMT).<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-Marsh_22-0\" class=\"reference\"><a href=\"#cite_note-Marsh-22\">&#91;22&#93;</a></sup><sup id=\"cite_ref-23\" class=\"reference\"><a href=\"#cite_note-23\">&#91;23&#93;</a></sup> Unlike their normal counterparts, CAFs do not retard cancer growth <i>in vitro</i>.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup> CAFs perform several functions that support tumor growth, such as secreting <a href=\"/wiki/Vascular_endothelial_growth_factor\" title=\"Vascular endothelial growth factor\">vascular endothelial growth factor</a> (VEGF), <a href=\"/wiki/Fibroblast_growth_factor\" title=\"Fibroblast growth factor\">fibroblast growth factors</a> (FGFs), <a href=\"/wiki/Platelet-derived_growth_factor\" title=\"Platelet-derived growth factor\">platelet-derived growth factor</a> (PDGF), and other pro-angiogenic signals to induce angiogenesis.<sup id=\"cite_ref-Weber_12-1\" class=\"reference\"><a href=\"#cite_note-Weber-12\">&#91;12&#93;</a></sup> CAFs can also secrete <a href=\"/wiki/Transforming_growth_factor_beta\" title=\"Transforming growth factor beta\">transforming growth factor beta</a> (TGF-\u03b2), which is associated with EMT, a process by which cancer cells can metastasize,<sup id=\"cite_ref-25\" class=\"reference\"><a href=\"#cite_note-25\">&#91;25&#93;</a></sup> and is associated with inhibiting <a href=\"/wiki/T_cell#Cytotoxic\" title=\"T cell\">cytotoxic T cells</a> and <a href=\"/wiki/Natural_killer_T_cell\" title=\"Natural killer T cell\">natural killer T cells</a>.<sup id=\"cite_ref-26\" class=\"reference\"><a href=\"#cite_note-26\">&#91;26&#93;</a></sup> As fibroblasts, CAFs are able to rework the ECM to include more paracrine survival signals such as IGF-1 and IGF-2, thus promoting survival of the surrounding cancer cells. CAFs are also associated with the <a href=\"/wiki/Reverse_Warburg_Effect\" class=\"mw-redirect\" title=\"Reverse Warburg Effect\">Reverse Warburg Effect</a> where the CAFs perform aerobic glycolysis and feed lactate to the cancer cells.<sup id=\"cite_ref-Hanahan_20-1\" class=\"reference\"><a href=\"#cite_note-Hanahan-20\">&#91;20&#93;</a></sup>\n</p><p>Several markers identify CAFs, including expression of <a href=\"/wiki/ACTA2\" title=\"ACTA2\">\u03b1 smooth muscle actin</a> (\u03b1SMA), <a href=\"/wiki/Vimentin\" title=\"Vimentin\">vimentin</a>, <a href=\"/wiki/PDGFRA\" title=\"PDGFRA\">platelet-derived growth factor receptor \u03b1</a> (PDGFR-\u03b1), <a href=\"/wiki/PDGFRB\" title=\"PDGFRB\">platelet-derived growth factor receptor \u03b2</a> (PDGFR-\u03b2), fibroblast specific protein 1 (FSP-1) and <a href=\"/wiki/Fibroblast_activation_protein,_alpha\" title=\"Fibroblast activation protein, alpha\">fibroblast activation protein</a> (FAP).<sup id=\"cite_ref-Marsh_22-1\" class=\"reference\"><a href=\"#cite_note-Marsh-22\">&#91;22&#93;</a></sup> None of these factors can be used to differentiate CAFs from all other cells by itself.\n</p>\n<h3><span class=\"mw-headline\" id=\"Myeloid-derived_suppressor_cells_and_tumor_associated_macrophages\">Myeloid-derived suppressor cells and tumor associated macrophages</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=7\" title=\"Edit section: Myeloid-derived suppressor cells and tumor associated macrophages\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Myeloid-derived suppressor cells (MDSCs) are a heterogenous population of cells of <a href=\"/wiki/Myeloid\" class=\"mw-redirect\" title=\"Myeloid\">myelogenous</a> origin with the potential to repress <a href=\"/wiki/T_cell\" title=\"T cell\">T cell</a> responses. They regulate wound repair and inflammation and are rapidly expanded in cancer, correlating with that signs of inflammation are seen in most if not all tumor sites.<sup id=\"cite_ref-Bronte_27-0\" class=\"reference\"><a href=\"#cite_note-Bronte-27\">&#91;27&#93;</a></sup><sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup> Tumors can produce exosomes that stimulate inflammation via MDSCs.<sup id=\"cite_ref-Mathias_29-0\" class=\"reference\"><a href=\"#cite_note-Mathias-29\">&#91;29&#93;</a></sup><sup id=\"cite_ref-Valenti_30-0\" class=\"reference\"><a href=\"#cite_note-Valenti-30\">&#91;30&#93;</a></sup> This group of cells include some <a href=\"/wiki/Macrophage#Cancer\" title=\"Macrophage\">tumor associated macrophages</a> (TAMs).<sup id=\"cite_ref-Bronte_27-1\" class=\"reference\"><a href=\"#cite_note-Bronte-27\">&#91;27&#93;</a></sup> TAMs are a central component in the strong link between <a href=\"/wiki/Inflammation#Cancer\" title=\"Inflammation\">chronic inflammation and cancer</a>. TAMs are recruited to the tumor as a response to cancer-associated inflammation.<sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup>  Unlike normal macrophages, TAMs lack cytotoxic activity.<sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup> TAMs have been induced in vitro by exposing macrophage progenitors to different immune regulatory cytokines, such as <a href=\"/wiki/Interleukin_4\" title=\"Interleukin 4\">interleukin 4</a> (IL-4) and <a href=\"/wiki/Interleukin_13\" title=\"Interleukin 13\">interleukin 13</a> (IL-13).<sup id=\"cite_ref-Hanahan_20-2\" class=\"reference\"><a href=\"#cite_note-Hanahan-20\">&#91;20&#93;</a></sup> TAMs gather in necrotic regions of tumors where they are associated with hiding cancer cells from normal immune cells by secreting <a href=\"/wiki/Interleukin_10\" title=\"Interleukin 10\">interleukin 10</a> (IL-10), aiding angiogenesis by secreting <a href=\"/wiki/Vascular_endothelial_growth_factor\" title=\"Vascular endothelial growth factor\">vascular endothelial growth factor</a> (VEGF) and <a href=\"/wiki/Nitric_oxide_synthase\" title=\"Nitric oxide synthase\">nitric oxide synthase</a>(NOS),<sup id=\"cite_ref-Weber_12-2\" class=\"reference\"><a href=\"#cite_note-Weber-12\">&#91;12&#93;</a></sup> supporting tumor growth by secreting <a href=\"/wiki/Epidermal_growth_factor\" title=\"Epidermal growth factor\">epidermal growth factor</a> (EGF)<sup id=\"cite_ref-Solinas_33-0\" class=\"reference\"><a href=\"#cite_note-Solinas-33\">&#91;33&#93;</a></sup> and remodeling the <a href=\"/wiki/Extracellular_matrix\" title=\"Extracellular matrix\">ECM</a>.<sup id=\"cite_ref-Weber_12-3\" class=\"reference\"><a href=\"#cite_note-Weber-12\">&#91;12&#93;</a></sup> TAMs show sluggish <a href=\"/wiki/NF-%CE%BAB\" title=\"NF-\u03baB\">NF-\u03baB</a> activation, which allows for the smoldering inflammation seen in cancer.<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup> An increased amount of TAMs is associated with worse prognosis.<sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup> TAMs represent a potential target for novel cancer therapies.\n</p><p>TAMs are associated with using <a href=\"/wiki/Exosome_(vesicle)\" title=\"Exosome (vesicle)\">exosomes</a> (vesicles used by mammalian cells to secrete intracellular contents) to deliver invasion-potentiating <a href=\"/wiki/MicroRNA\" title=\"MicroRNA\">microRNA</a> (miRNA) into cancerous cells, specifically breast cancer cells.<sup id=\"cite_ref-Mathias_29-1\" class=\"reference\"><a href=\"#cite_note-Mathias-29\">&#91;29&#93;</a></sup><sup id=\"cite_ref-37\" class=\"reference\"><a href=\"#cite_note-37\">&#91;37&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Neutrophils\">Neutrophils</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=8\" title=\"Edit section: Neutrophils\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Neutrophils\" class=\"mw-redirect\" title=\"Neutrophils\">Neutrophils</a> are polymorphonuclear immune cells that are critical components of the <a href=\"/wiki/Innate_immune_system\" title=\"Innate immune system\">innate immune system</a>. Neutrophils can accumulate in tumors and in some cancers, such as lung adenocarcinoma, their abundance at the tumor site is associated with worsened disease prognosis.<sup id=\"cite_ref-38\" class=\"reference\"><a href=\"#cite_note-38\">&#91;38&#93;</a></sup><sup id=\"cite_ref-39\" class=\"reference\"><a href=\"#cite_note-39\">&#91;39&#93;</a></sup><sup id=\"cite_ref-40\" class=\"reference\"><a href=\"#cite_note-40\">&#91;40&#93;</a></sup> Neutrophil numbers (and myeloid cell precursors) in the blood can be increased in some patients with solid tumors.<sup id=\"cite_ref-41\" class=\"reference\"><a href=\"#cite_note-41\">&#91;41&#93;</a></sup><sup id=\"cite_ref-42\" class=\"reference\"><a href=\"#cite_note-42\">&#91;42&#93;</a></sup><sup id=\"cite_ref-43\" class=\"reference\"><a href=\"#cite_note-43\">&#91;43&#93;</a></sup> Experiments in mice have mainly shown that tumor-associated neutrophils exhibit tumor-promoting functions,<sup id=\"cite_ref-44\" class=\"reference\"><a href=\"#cite_note-44\">&#91;44&#93;</a></sup><sup id=\"cite_ref-45\" class=\"reference\"><a href=\"#cite_note-45\">&#91;45&#93;</a></sup><sup id=\"cite_ref-46\" class=\"reference\"><a href=\"#cite_note-46\">&#91;46&#93;</a></sup><sup id=\"cite_ref-47\" class=\"reference\"><a href=\"#cite_note-47\">&#91;47&#93;</a></sup><sup id=\"cite_ref-48\" class=\"reference\"><a href=\"#cite_note-48\">&#91;48&#93;</a></sup><sup id=\"cite_ref-49\" class=\"reference\"><a href=\"#cite_note-49\">&#91;49&#93;</a></sup> but a smaller number of studies show that neutrophils can also inhibit tumor growth.<sup id=\"cite_ref-50\" class=\"reference\"><a href=\"#cite_note-50\">&#91;50&#93;</a></sup><sup id=\"cite_ref-51\" class=\"reference\"><a href=\"#cite_note-51\">&#91;51&#93;</a></sup> Neutrophil phenotypes are diverse and distinct neutrophil phenotypes in tumors have been identified.<sup id=\"cite_ref-52\" class=\"reference\"><a href=\"#cite_note-52\">&#91;52&#93;</a></sup><sup id=\"cite_ref-53\" class=\"reference\"><a href=\"#cite_note-53\">&#91;53&#93;</a></sup> In mice, neutrophils and \u2018granulocytic myeloid derived suppressor cells\u2019 are often identified by the same cell surface antibodies using flow cytometry and it is unclear whether these are overlapping or distinct populations.<sup id=\"cite_ref-54\" class=\"reference\"><a href=\"#cite_note-54\">&#91;54&#93;</a></sup><sup id=\"cite_ref-55\" class=\"reference\"><a href=\"#cite_note-55\">&#91;55&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Tumor_infiltrating_lymphocytes\">Tumor infiltrating lymphocytes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=9\" title=\"Edit section: Tumor infiltrating lymphocytes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p><a href=\"/wiki/Tumor_infiltrating_lymphocyte\" class=\"mw-redirect\" title=\"Tumor infiltrating lymphocyte\">Tumor infiltrating lymphocytes</a> (TILs) are lymphocytes that penetrate a tumor. TILs have a common origin with myelogenous cells at the <a href=\"/wiki/Hematopoietic_stem_cell\" title=\"Hematopoietic stem cell\">hematopoietic stem cell</a>, but diverge in development. Concentration is generally positively correlated.<sup id=\"cite_ref-Solinas_33-1\" class=\"reference\"><a href=\"#cite_note-Solinas-33\">&#91;33&#93;</a></sup> However, only in melanoma has autologous TIL transplant succeeded as a treatment.<sup id=\"cite_ref-56\" class=\"reference\"><a href=\"#cite_note-56\">&#91;56&#93;</a></sup> Cancer cells induce apoptosis of activated T cells (a class of lymphocyte) by secreting <a href=\"/wiki/Exosome_(vesicle)\" title=\"Exosome (vesicle)\">exosomes</a> containing death ligands such as FasL and TRAIL, and via the same method, turn off the normal cytotoxic response of <a href=\"/wiki/Natural_killer_cell\" title=\"Natural killer cell\">natural killer cells</a> (NK cells).<sup id=\"cite_ref-Valenti_30-1\" class=\"reference\"><a href=\"#cite_note-Valenti-30\">&#91;30&#93;</a></sup><sup id=\"cite_ref-57\" class=\"reference\"><a href=\"#cite_note-57\">&#91;57&#93;</a></sup> This suggests that cancer cells actively work to restrain TILs.\n</p>\n<h3><span class=\"mw-headline\" id=\"Extracellular_matrix_remodeling\">Extracellular matrix remodeling</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=10\" title=\"Edit section: Extracellular matrix remodeling\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Fibroblasts are in charge of laying down most of the <a href=\"/wiki/Collagens\" class=\"mw-redirect\" title=\"Collagens\">collagens</a>, <a href=\"/wiki/Elastin\" title=\"Elastin\">elastin</a>, <a href=\"/wiki/Glycosaminoglycans\" class=\"mw-redirect\" title=\"Glycosaminoglycans\">glycosaminoglycans</a>, <a href=\"/wiki/Proteoglycans\" class=\"mw-redirect\" title=\"Proteoglycans\">proteoglycans</a> (e.g. <a href=\"/wiki/Perlecan\" title=\"Perlecan\">perlecan</a>), and <a href=\"/wiki/Glycoproteins\" class=\"mw-redirect\" title=\"Glycoproteins\">glycoproteins</a> in the ECM. As many fibroblasts are transformed into CAFs during carcinogenesis, this reduces the amount of ECM produced and the ECM that is produced can be malformed, like collagen being loosely woven and non-planar, possibly even curved.<sup id=\"cite_ref-Tisty_58-0\" class=\"reference\"><a href=\"#cite_note-Tisty-58\">&#91;58&#93;</a></sup> In addition, CAFs produce <a href=\"/wiki/Matrix_metalloproteinase\" title=\"Matrix metalloproteinase\">matrix metalloproteinases</a> (MMP) that cleave the proteins within the ECM.<sup id=\"cite_ref-Weber_12-4\" class=\"reference\"><a href=\"#cite_note-Weber-12\">&#91;12&#93;</a></sup> CAFs are also able to disrupt the ECM via force, generating a track that a carcinoma cell can follow.<sup id=\"cite_ref-59\" class=\"reference\"><a href=\"#cite_note-59\">&#91;59&#93;</a></sup> In either case, destruction of the ECM allows cancer cells to escape from their in situ location and <a href=\"/wiki/Intravasate\" class=\"mw-redirect\" title=\"Intravasate\">intravasate</a> into the blood stream where they can metastasize systematically. It can also provide passage for endothelial cells to complete angiogenesis to the tumor site.\n</p><p>Destruction of the ECM also modulates the signaling cascades controlled by the interaction of cell-surface receptors and the ECM,  and it also reveals binding sites previously hidden, like the integrin <a href=\"/wiki/Alpha-v_beta-3\" title=\"Alpha-v beta-3\">alpha-v beta-3</a> (\u03b1V\u03b23) on the surface of melanoma cells can be ligated to rescue the cells from apoptosis after degradation of collagen.<sup id=\"cite_ref-Pupa_60-0\" class=\"reference\"><a href=\"#cite_note-Pupa-60\">&#91;60&#93;</a></sup><sup id=\"cite_ref-61\" class=\"reference\"><a href=\"#cite_note-61\">&#91;61&#93;</a></sup> In addition, the degradation products may have downstream effects as well that can increase cancer cell tumorigenicity and can serve as potential biomarkers.<sup id=\"cite_ref-Pupa_60-1\" class=\"reference\"><a href=\"#cite_note-Pupa-60\">&#91;60&#93;</a></sup> ECM destruction also releases the cytokines and growth factors stored therein (for example, VEGF, <a href=\"/wiki/Basic_fibroblast_growth_factor\" title=\"Basic fibroblast growth factor\">basic fibroblast growth factor</a> (bFGF), <a href=\"/wiki/Insulin-like_growth_factor\" title=\"Insulin-like growth factor\">insulin-like growth factors</a> (IGF1 and IGF2), TGF-\u03b2, EGF, <a href=\"/wiki/Heparin-binding_EGF-like_growth_factor\" title=\"Heparin-binding EGF-like growth factor\">heparin-binding EGF-like growth factor</a> (HB-EGF), and <a href=\"/wiki/Tumor_necrosis_factor\" class=\"mw-redirect\" title=\"Tumor necrosis factor\">tumor necrosis factor</a> (TNF), which can increase the growth of the tumor.<sup id=\"cite_ref-Tisty_58-1\" class=\"reference\"><a href=\"#cite_note-Tisty-58\">&#91;58&#93;</a></sup><sup id=\"cite_ref-62\" class=\"reference\"><a href=\"#cite_note-62\">&#91;62&#93;</a></sup> Cleavage of ECM components can also release cytokines that inhibit tumorigenesis, such as degradation of certain types of collagen can form <a href=\"/wiki/Endostatin\" title=\"Endostatin\">endostatin</a>, restin, canstatin and <a href=\"/wiki/Tumstatin\" title=\"Tumstatin\">tumstatin</a>, which have antiangiogenic functions.<sup id=\"cite_ref-Tisty_58-2\" class=\"reference\"><a href=\"#cite_note-Tisty-58\">&#91;58&#93;</a></sup>\n</p><p>ECM stiffening is associated with tumor progression.<sup id=\"cite_ref-physicalMicroenvironment_3-2\" class=\"reference\"><a href=\"#cite_note-physicalMicroenvironment-3\">&#91;3&#93;</a></sup><sup id=\"cite_ref-63\" class=\"reference\"><a href=\"#cite_note-63\">&#91;63&#93;</a></sup> This stiffening may be partially attributed to CAFs secreting <a href=\"/wiki/Lysyl_oxidase\" title=\"Lysyl oxidase\">lysyl oxidase</a> (LOX), an enzyme that cross-links the collagen IV found in the ECM.<sup id=\"cite_ref-Marsh_22-2\" class=\"reference\"><a href=\"#cite_note-Marsh-22\">&#91;22&#93;</a></sup><sup id=\"cite_ref-Levental_64-0\" class=\"reference\"><a href=\"#cite_note-Levental-64\">&#91;64&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Relation_to_T_cells\">Relation to T cells</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=11\" title=\"Edit section: Relation to T cells\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>Preclinical mice studies implicate CAFs, TAMs and <a href=\"/wiki/Myelomonocytic\" class=\"mw-redirect\" title=\"Myelomonocytic\">myelomonocytic</a> cells (including several myeloid-derived suppressor cells (MDSCs)) in restricting T cell accumulation near cancer cells. Overcoming this restriction, combined with a <a href=\"/wiki/Immune_checkpoint_inhibitor\" class=\"mw-redirect\" title=\"Immune checkpoint inhibitor\">T cell checkpoint antagonist</a>, revealed enhanced antitumor effects. Tumor vasculature also plays an active role in restricting T cell entry into the TME.<sup id=\"cite_ref-:0_2-4\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p><p>T cells reach tumor sites via the circulatory system. The TME appears to preferentially recruit other immune cells over T cells from that system. One such mechanism is the release of cell-type specific <a href=\"/wiki/Chemokines\" class=\"mw-redirect\" title=\"Chemokines\">chemokines</a>. Another is the TME's capacity to posttranslationally alter chemokines. For example, the production of reactive nitrogen species by MDSCs within the TME induces nitration of <a href=\"/wiki/CCL2\" title=\"CCL2\">CCL2</a> (N-CCL2), which traps T cells in the stroma of colon and prostate cancers. N-CCL2 does attract monocytes. CCL2 nitration inhibitors enhanced the accumulation of TILs in the corresponding animal models and resulted in improved efficacy of ACT.<sup id=\"cite_ref-:0_2-5\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p><p>Another T cell inhibitor appears to be the <a href=\"/wiki/Apoptosis\" title=\"Apoptosis\">apoptosis</a> inducer <a href=\"/wiki/Fas_ligand\" title=\"Fas ligand\">Fas ligand</a> (FasL) that is found in the tumor vasculature of tumor types including ovarian, colon, prostate, breast, bladder and renal cancer. High levels of endothelial FasL are accompanied by few CD8<sup>+</sup> T cells, but abundant T<sub>reg</sub> cells. In preclinical models inhibiting FasL increased the ratio of tumor-rejecting T cells to T<sub>reg</sub> cells and T cell\u2013dependent tumor suppression. FasL inhibition also improves ACT efficacy.<sup id=\"cite_ref-:0_2-6\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p><p>In ovarian cancer elevated VEGF levels and expression of the immune regulatory ligand B7H3 (<a href=\"/wiki/CD276\" title=\"CD276\">CD276</a>), or the <a href=\"/wiki/Endothelin\" title=\"Endothelin\">endothelin</a> B receptor (ET<sub>B</sub>R) on tumor vessels correlate with decreased T cell infiltration and worse clinical outcome. Pharmacological inhibition of ET<sub>B</sub>R increased T cell adhesion to endothelial cells in an <a href=\"/wiki/Intercellular_adhesion_molecule-1\" class=\"mw-redirect\" title=\"Intercellular adhesion molecule-1\">intercellular adhesion molecule-1</a> (ICAM-1)\u2013dependent manner, increasing TIL numbers in mice and a corresponding tumor response. Anti-angiogenic inhibitors targeting VEGF and its receptor VEGFR2 (approved for treatment of multiple cancers) induce vascular normalization. This, in turn, increases TILs and improves ACT and vaccine efficacy in preclinical models. VEGF impairs DC maturation, offering another means to enhance intratumoral immune responses. Deleting the regulator of G-protein signaling, <a href=\"/wiki/RGS5\" title=\"RGS5\">Rgs5</a> reduced vessel leakiness and hypoxia, enhanced T cell infiltration into mouse pancreatic neuroendocrine tumors, and prolonged animal survival. Vascular normalization is thus likely more effective than vessel destruction. Targeted delivery of t<a href=\"/wiki/Tumor_necrosis_factor-%CE%B1\" class=\"mw-redirect\" title=\"Tumor necrosis factor-\u03b1\">umor necrosis factor-\u03b1</a> (TNF-\u03b1) was reported to normalize tumor blood vessels, increase CD8<sup>+</sup> T cell infiltration and enhance vaccine and ACT therapies, unlike inflammatory cytokines <a href=\"/wiki/Interferon-%CE%B3\" class=\"mw-redirect\" title=\"Interferon-\u03b3\">interferon-\u03b3</a> (IFN-\u03b3).<sup id=\"cite_ref-:0_2-7\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Reproduction\">Reproduction</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=12\" title=\"Edit section: Reproduction\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>T cells must reproduce after arriving at the tumor site to further increase their numbers, survive the TME's hostile elements and migrate through the stroma to the cancer cells. The TME obstructs all three activities. The draining lymph nodes are the likely location for T cell clonal reproduction, although this also occurs within the tumor. Preclinical models suggest that the TME is the major site of cancer-specific T cell cloning and that the CD8<sup>+</sup> T cell replicative response there is orchestrated by the <a href=\"/wiki/CD103\" class=\"mw-redirect\" title=\"CD103\">CD103</a><sup>+</sup>, Baft3-dependent DC, which can efficiently cross-present cancer cell antigens, suggesting that therapeutic interventions that enhance CD103<sup>+</sup> contribute to tumor control. Among such strategies are antibodies to the <a href=\"/wiki/Interleukin-10_receptor\" title=\"Interleukin-10 receptor\">interleukin-10 receptor</a> (IL10R). In a mammary carcinoma mouse model it neutralized the effects of TAM-produced <a href=\"/wiki/Interleukin_10\" title=\"Interleukin 10\">IL10</a>, relieved the suppression of <a href=\"/wiki/Interleukin_12\" title=\"Interleukin 12\">IL12</a> production by intratumoral DCs and improved the CD8<sup>+</sup> T cell\u2013dependent antitumor effects of chemotherapy. A similar outcome was achieved by neutralizing <a href=\"/wiki/Macrophage_colony-stimulating_factor\" title=\"Macrophage colony-stimulating factor\">macrophage colony-stimulating factor</a> 1, which impaired the intratumoral accumulation of TAMs. Another strategy is the administration of antibody-interferon-\u03b2 (IFN-\u03b2) complexes that activate intratumoral DCs to cross-present antigen to CD8<sup>+</sup> T cells. They are targeted against oncogenic receptors such as <a href=\"/wiki/Epidermal_growth_factor_receptor\" title=\"Epidermal growth factor receptor\">epidermal growth factor receptor</a> (EGFR).<sup id=\"cite_ref-:0_2-8\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p><p>Tumor eradication resulted when PD-L1 (also induced by IFN-\u03b2 acting on DCs) was neutralized. DC function also may be adversely affected by the TME's hypoxic conditions, which induces PD-L1 expression on DCs and other myelomonocytic cells as a result of <a href=\"/wiki/Hypoxia-inducible_factors\" title=\"Hypoxia-inducible factors\">hypoxia-inducible factors</a>-1\u03b1 (HIF-1\u03b1) binding directly to a hypoxia-responsive element in the PD-L1 promoter. Even the aerobic glycolysis of cancer cells may antagonize local immune reactions via increasing lactate production, which induces the M2 TAM polarization. An M1 to M2 phenotypic transition of intratumoral <a href=\"/wiki/Macrophages\" class=\"mw-redirect\" title=\"Macrophages\">macrophages</a> was reported after the induction of cancer cell apoptosis in human and mouse gastrointestinal stromal tumors by KIT <a href=\"/wiki/Oncoprotein\" class=\"mw-redirect\" title=\"Oncoprotein\">oncoprotein</a> inhibitor <a href=\"/wiki/Imatinib\" title=\"Imatinib\">imatinib</a>. The designation of M1 and M2 polarization states over-simplify macrophage biology, since at least six different TAM subpopulations are known. Therefore, TME TAM phenotype descriptors are likely important.<sup id=\"cite_ref-:0_2-9\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p><p>The TME may also directly impair intratumoral T cell proliferation. <a href=\"/wiki/Indole_2,3-dioxygenase\" title=\"Indole 2,3-dioxygenase\">Indole 2,3-dioxygenase</a> (IDO)\u2014which can be expressed by DCs, MDSCs and cancer cells\u2014<a href=\"/wiki/Catabolism\" title=\"Catabolism\">catabolizes</a> <a href=\"/wiki/Tryptophan\" title=\"Tryptophan\">tryptophan</a> and generates <a href=\"/wiki/Kynurenine\" title=\"Kynurenine\">kynurenine</a>. Both the deprivation of tryptophan and the generation of its metabolic product inhibit clonal T cell expansion. IDO also promotes the conversion of T cells to T<sub>reg</sub> cells and increases <a href=\"/wiki/Interleukin_6\" title=\"Interleukin 6\">IL-6</a> expression, which augments MDSC functions. Accordingly, IDO1 genetic deficiency is associated with reduced tumor burden and metastasis and enhanced survival in mouse models of lung and breast cancer. The therapeutic potential of inhibiting IDO, in combination with anti-CTLA-4 was demonstrated in the B16 melanoma model and was associated with increased intratumoral T cells. IDO's capacity to block T<sub>reg</sub> cell to helperlike cell reprogramming by sustaining transcription factor <a href=\"/wiki/Eos_(protein)\" title=\"Eos (protein)\">Eos</a> and the transcriptional program it regulates, also suppresses the immune response.<sup id=\"cite_ref-:0_2-10\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Apoptosis\">Apoptosis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=13\" title=\"Edit section: Apoptosis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>The TME can limit T cell  viability. Both IDO and PD-L1 may induce T cell apoptosis. Myelomonocytic cell products that cause apoptosis include FasL, TNF-\u03b1, and <a href=\"/wiki/TNF-related_apoptosis-inducing_ligand\" class=\"mw-redirect\" title=\"TNF-related apoptosis-inducing ligand\">TNF-related apoptosis-inducing ligand</a> (TRAIL). Ppp2r2d is a key regulator promoting T cell apoptosis and suppressing T cell proliferation.<sup id=\"cite_ref-:0_2-11\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"TAMs_and_MDSCs\">TAMs and MDSCs</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=14\" title=\"Edit section: TAMs and MDSCs\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Targeting intratumoral TAMs and MDSCs can also reduce tumor burdens in preclinical models, in both T cell\u2013dependent and T cell\u2013independent ways. For instance, inhibiting <a href=\"/wiki/CCR2\" title=\"CCR2\">chemokine receptor type 2</a> (CCR2), <a href=\"/wiki/Colony-stimulating_factor-1_receptor\" class=\"mw-redirect\" title=\"Colony-stimulating factor-1 receptor\">colony-stimulating factor-1 receptor</a> (CSF-1R) and <a href=\"/wiki/Granulocyte_macrophage_colony-stimulating_factor\" class=\"mw-redirect\" title=\"Granulocyte macrophage colony-stimulating factor\">granulocyte macrophage colony-stimulating factor</a> (GM-CSF) in preclinical models of melanoma, pancreatic, breast, and prostatic carcinoma increased T cells and restricted tumor growth. The effect was enhanced by anti-CTLA-4 or anti-PD-1/PD-L1. These studies did not determine whether the increases in T cells were a consequence of viability or replication.<sup id=\"cite_ref-:0_2-12\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p><p>Inhibition of CSF-1R in a preclinical proneural glioblastoma multiforme model and in patient-derived <a href=\"/wiki/Glioma\" title=\"Glioma\">glioma</a> <a href=\"/wiki/Xenografts\" class=\"mw-redirect\" title=\"Xenografts\">xenografts</a> increased survival and shrank established tumors in an apparently T cell\u2013independent manner that correlated with the reprogramming of <a href=\"/wiki/Macrophages\" class=\"mw-redirect\" title=\"Macrophages\">macrophages</a> away from an M2 phenotype. Similarly, an activator of TAMs, an agonistic antibody to CD40, when administered in combination with the chemotherapeutic drug <a href=\"/wiki/Gemcitabine\" title=\"Gemcitabine\">gemcitabine</a>, suppressed mouse PDA growth in a T cell\u2013independent manner, suggesting that stimulated macrophages may have anticancer functions.<sup id=\"cite_ref-:0_2-13\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p><p>B cells regulate TAM phenotypes in squamous cell carcinoma TME. Correspondingly, B cell depletion reprogrammed TAMs, thus reducing their suppression of CD8 cells and enhancing chemotherapy. An autochthonous melanoma mouse model depleted T<sub>reg</sub> cells and neutralized IL-10, revealing tumor-killing properties. TAMs mediate the effects of antitumor antibodies and genetically engineered ligands that interact with <a href=\"/wiki/CD47\" title=\"CD47\">CD47</a> to prevent the CD47/<a href=\"/wiki/Signal-regulatory_protein_alpha\" title=\"Signal-regulatory protein alpha\">signal regulatory protein\u2013\u03b1</a> (SIRP\u03b1) signaling system from suppressing antibody-coated cancer cell <a href=\"/wiki/Phagocytosis\" title=\"Phagocytosis\">phagocytosis</a>.<sup id=\"cite_ref-:0_2-14\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Spatial_distribution\">Spatial distribution</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=15\" title=\"Edit section: Spatial distribution\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>CAFs restrict T cell distribution by two means. They can physically exclude them, as mediated by their extracellular matrix. T cell motility was higher in regions of loose <a href=\"/wiki/Fibronectin\" title=\"Fibronectin\">fibronectin</a> and collagen than in dense matrix areas surrounding tumor nests. <a href=\"/wiki/Collagenase\" title=\"Collagenase\">Collagenase</a> added to reduce matrix rigidity or <a href=\"/wiki/Chemokine\" title=\"Chemokine\">chemokine</a> <a href=\"/wiki/CCL5\" title=\"CCL5\">CCL5</a> experimentally produced by tumor cells increased movement into contact with cancer cells.\n</p><p>They can also exclude them via biosynthesis of <a href=\"/wiki/CXCL12\" class=\"mw-redirect\" title=\"CXCL12\">CXCL12</a>. Conditionally depleting these cells from the stroma of an ectopic, transplanted tumor and of an autochthonous pancreatic ductal <a href=\"/wiki/Adenocarcinoma\" title=\"Adenocarcinoma\">adenocarcinoma</a> (PDA) allowed T cells to rapidly control tumor growth. However, the depletion must be limited to the TME, because these cells carry out essential functions in several normal tissues. \u201cReprogramming\u201d FAP<sup>+</sup> cells in the TME with a <a href=\"/wiki/Vitamin_D\" title=\"Vitamin D\">vitamin D</a> analog may neutralize them. Another approach may block their immune suppressive mechanism. In a preclinical PDA mouse model, FAP<sup>+</sup> CAFs produced the chemokine CXCL12, which is bound by PDA cancer cells. Because FAP<sup>+</sup> stromal cells also accumulate in nontransformed, inflammatory lesions, this \u201ccoating\u201d of cancer cells may reflect a means by which \u201cinjured\u201d epithelial cells protect themselves from immune attack. Administering an inhibitor of CXCL12 receptor <a href=\"/wiki/CXCR4\" title=\"CXCR4\">CXCR4</a> caused the rapid spread of T cells among cancer cells, arrested tumor growth and stimulated tumor sensitivity to anti-PD-L1.\n</p>\n<h2><span class=\"mw-headline\" id=\"Clinical_implications\">Clinical implications</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=16\" title=\"Edit section: Clinical implications\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<h3><span class=\"mw-headline\" id=\"Drug_development\">Drug development</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=17\" title=\"Edit section: Drug development\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<p>High throughput cancer therapeutics screens are performed <i>in vitro</i> without the accompanying microenvironment. However, studies also investigate the effects of supportive stroma cells and their resistance to therapy. The latter studies revealed interesting therapeutic targets in the microenvironment including <a href=\"/wiki/Integrins\" class=\"mw-redirect\" title=\"Integrins\">integrins</a> and <a href=\"/wiki/Chemokines\" class=\"mw-redirect\" title=\"Chemokines\">chemokines</a>.<sup id=\"cite_ref-pmid21749361_65-0\" class=\"reference\"><a href=\"#cite_note-pmid21749361-65\">&#91;65&#93;</a></sup> These were missed by initial screens for anti-cancer drugs and might also help explain why so few drugs are highly potent <i>in vivo</i>.\n</p><p>Nanocarrier vehicles (~20\u2013200&#160;nm in diameter) can transport drugs and other therapeutic molecules. These therapies can be targeted to selectively extravasate through tumor vasculature via the EPR effect. Nanocarriers are now considered the gold standard of targeted cancer therapy because it can target tumors that are hypovascularized, such as prostate and pancreatic tumors.<sup id=\"cite_ref-Danhier_11-2\" class=\"reference\"><a href=\"#cite_note-Danhier-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-66\" class=\"reference\"><a href=\"#cite_note-66\">&#91;66&#93;</a></sup> These efforts include protein <a href=\"/wiki/Capsids\" class=\"mw-redirect\" title=\"Capsids\">capsids</a><sup id=\"cite_ref-67\" class=\"reference\"><a href=\"#cite_note-67\">&#91;67&#93;</a></sup> and <a href=\"/wiki/Liposomes\" class=\"mw-redirect\" title=\"Liposomes\">liposomes</a>.<sup id=\"cite_ref-68\" class=\"reference\"><a href=\"#cite_note-68\">&#91;68&#93;</a></sup> However, as some important, normal tissues, such as the liver and kidneys, also have fenestrated endothelium, the nanocarrier size (10\u2013100&#160;nm, with greater retention in tumors seen in using larger nanocarriers) and charge (anionic or neutral) must be considered.<sup id=\"cite_ref-Danhier_11-3\" class=\"reference\"><a href=\"#cite_note-Danhier-11\">&#91;11&#93;</a></sup> Lymphatic vessels do not usually develop with the tumor, leading to increased <a href=\"/wiki/Interstitial_fluid\" class=\"mw-redirect\" title=\"Interstitial fluid\">interstitial fluid</a> pressure, which may block tumor access.<sup id=\"cite_ref-Danhier_11-4\" class=\"reference\"><a href=\"#cite_note-Danhier-11\">&#91;11&#93;</a></sup><sup id=\"cite_ref-69\" class=\"reference\"><a href=\"#cite_note-69\">&#91;69&#93;</a></sup>\n</p>\n<h3><span class=\"mw-headline\" id=\"Therapies\">Therapies</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=18\" title=\"Edit section: Therapies\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h3>\n<h4><span class=\"mw-headline\" id=\"Antibodies\">Antibodies</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=19\" title=\"Edit section: Antibodies\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p><a href=\"/wiki/Monoclonal_antibody\" title=\"Monoclonal antibody\">Monoclonal antibody</a> <a href=\"/wiki/Bevacizumab\" title=\"Bevacizumab\">Bevacizumab</a> is clinically approved in the US to treat a variety of cancers by targeting <a href=\"/wiki/Vascular_endothelial_growth_factor\" title=\"Vascular endothelial growth factor\">VEGF-A</a>, which is produced by both CAFs and TAMs, thus slowing <a href=\"/wiki/Angiogenesis\" title=\"Angiogenesis\">angiogenesis</a>.\n</p><p>Targeting immunoregulatory membrane receptors succeeded in some patients with melanoma, <a href=\"/wiki/Non-small-cell_lung_carcinoma\" title=\"Non-small-cell lung carcinoma\">non-small-cell lung carcinoma</a>, urothelial bladder cancer and renal cell cancer. In mice, anti-<a href=\"/wiki/CTLA-4\" title=\"CTLA-4\">CTLA-4</a> therapy leads to clearance from the tumor of <a href=\"/wiki/FOXP3\" title=\"FOXP3\">Foxp3</a><sup>+</sup> <a href=\"/wiki/Regulatory_T_cells\" class=\"mw-redirect\" title=\"Regulatory T cells\">regulatory T cells</a> (T<sub>reg</sub> cells) whose presence may impair effector T cell function. Similarly anti-PD-1/anti-PD-L1 therapy blocks the inhibitory PD-1 receptor. Other, potentially more fundamental TME inhibitory reactions (as in microsatellite stable <a href=\"/wiki/Colorectal_cancer\" title=\"Colorectal cancer\">colorectal cancer</a>, ovarian cancer, prostate cancer, and PDA have yet to be overcome. The TME appears to aid in excluding killer T cells from the vicinity of cancer cells.<sup id=\"cite_ref-:0_2-15\" class=\"reference\"><a href=\"#cite_note-:0-2\">&#91;2&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Kinase_inhibitors\">Kinase inhibitors</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=20\" title=\"Edit section: Kinase inhibitors\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Many other small molecule <a href=\"/wiki/Receptor_tyrosine_kinase\" title=\"Receptor tyrosine kinase\">kinase inhibitors</a> block the receptors for the growth factors released, thus making the cancer cell deaf to much of the <a href=\"/wiki/Paracrine\" class=\"mw-redirect\" title=\"Paracrine\">paracrine</a> signaling produced by CAFs and TAMs. These inhibitors include <a href=\"/wiki/Sunitinib\" title=\"Sunitinib\">Sunitinib</a>, <a href=\"/wiki/Pazopanib\" title=\"Pazopanib\">Pazopanib</a>, <a href=\"/wiki/Sorafenib\" title=\"Sorafenib\">Sorafenib</a> and <a href=\"/wiki/Axitinib\" title=\"Axitinib\">Axitinib</a>, all of which inhibit <a href=\"/wiki/Platelet_derived_growth_factor_receptor\" class=\"mw-redirect\" title=\"Platelet derived growth factor receptor\">platelet derived growth factor receptors</a> (PDGF-Rs) and <a href=\"/wiki/VEGF_receptors\" class=\"mw-redirect\" title=\"VEGF receptors\">VEGF receptors</a> (VEGFRs). <a href=\"/wiki/Cannabidiol\" title=\"Cannabidiol\">Cannabidiol</a> (a <a href=\"/wiki/Cannabis\" title=\"Cannabis\">cannabis</a> derivate without psychoactive effects) has also been shown to inhibit the expression of VEGF in <a href=\"/wiki/Kaposi%27s_sarcoma\" title=\"Kaposi&#39;s sarcoma\">Kaposi's sarcoma</a>.<sup id=\"cite_ref-70\" class=\"reference\"><a href=\"#cite_note-70\">&#91;70&#93;</a></sup> <a href=\"/wiki/Natalizumab\" title=\"Natalizumab\">Natalizumab</a> is a <a href=\"/wiki/Monoclonal_antibody\" title=\"Monoclonal antibody\">monoclonal antibody</a> that targets a molecule responsible for cell <a href=\"/wiki/Adhesion\" title=\"Adhesion\">adhesion</a> (integrin VLA-4) and has promising <i>in vitro</i> activity in B cell <a href=\"/wiki/Lymphomas\" class=\"mw-redirect\" title=\"Lymphomas\">lymphomas</a> and <a href=\"/wiki/Leukemias\" class=\"mw-redirect\" title=\"Leukemias\">leukemias</a>.<sup id=\"cite_ref-pmid21749361_65-1\" class=\"reference\"><a href=\"#cite_note-pmid21749361-65\">&#91;65&#93;</a></sup>\n</p><p><a href=\"/wiki/Trabectedin\" title=\"Trabectedin\">Trabectedin</a> has immunomodulatory effects that inhibit TAMs.<sup id=\"cite_ref-Solinas_33-2\" class=\"reference\"><a href=\"#cite_note-Solinas-33\">&#91;33&#93;</a></sup>\n</p>\n<h4><span class=\"mw-headline\" id=\"Liposomes\">Liposomes</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=21\" title=\"Edit section: Liposomes\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h4>\n<p>Liposome formulations that encapsulate anti-cancer drugs for selective uptake to tumors via the EPR effect include: <a href=\"/wiki/Doxorubicin#Liposomal_formulations\" title=\"Doxorubicin\">Doxil</a> and <a href=\"/wiki/Doxorubicin#Liposomal_formulations\" title=\"Doxorubicin\">Myocet</a>, both of which encapsulate <a href=\"/wiki/Doxorubicin\" title=\"Doxorubicin\">doxorubicin</a> (a DNA intercalator and common chemotherapeutic); DaunoXome, which encapsulates <a href=\"/wiki/Daunorubicin\" title=\"Daunorubicin\">daunorubicin</a> (a similar DNA intercalator); and Onco-TCS, which encapsulates <a href=\"/wiki/Vincristine\" title=\"Vincristine\">vincristine</a> (a molecule that induces formation of microtubules, dysregulating cell division). Another novel utilization of the EPR effect comes from <a href=\"/wiki/Protein-bound_paclitaxel\" title=\"Protein-bound paclitaxel\">Protein-bound paclitaxel</a> (marketed under the trade name Abraxane) where <a href=\"/wiki/Paclitaxel\" title=\"Paclitaxel\">paclitaxel</a> (a molecule which dysregulates cell division via stabilization of microtubules) is bound to <a href=\"/wiki/Albumin\" title=\"Albumin\">albumin</a> to add bulk and aid delivery.\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=22\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p><a href=\"/wiki/Tumor-associated_endothelial_cells\" class=\"mw-redirect\" title=\"Tumor-associated endothelial cells\">Tumor-associated endothelial cells</a>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Tumor_microenvironment&amp;action=edit&amp;section=23\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-1\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation web\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.cancer.gov/dictionary?cdrid=561725\">\"NCI Dictionary of Cancer Terms\"</a>. <i>National Cancer Institute</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Cancer+Institute&amp;rft.atitle=NCI+Dictionary+of+Cancer+Terms&amp;rft_id=http%3A%2F%2Fwww.cancer.gov%2Fdictionary%3Fcdrid%3D561725&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:0-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:0_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-:0_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-:0_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-:0_2-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-:0_2-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-:0_2-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-:0_2-7\"><sup><i><b>h</b></i></sup></a> <a href=\"#cite_ref-:0_2-8\"><sup><i><b>i</b></i></sup></a> <a href=\"#cite_ref-:0_2-9\"><sup><i><b>j</b></i></sup></a> <a href=\"#cite_ref-:0_2-10\"><sup><i><b>k</b></i></sup></a> <a href=\"#cite_ref-:0_2-11\"><sup><i><b>l</b></i></sup></a> <a href=\"#cite_ref-:0_2-12\"><sup><i><b>m</b></i></sup></a> <a href=\"#cite_ref-:0_2-13\"><sup><i><b>n</b></i></sup></a> <a href=\"#cite_ref-:0_2-14\"><sup><i><b>o</b></i></sup></a> <a href=\"#cite_ref-:0_2-15\"><sup><i><b>p</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation web\">Joyce, Johanna A.; Fearon, Douglas T. (3 April 2015). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencemag.org/content/348/6230/74.full\">\"T cell exclusion, immune privilege, and the tumor microenvironment\"</a>. Science Magazine. pp.&#160;74\u201380. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.aaa6204\">10.1126/science.aaa6204</a><span class=\"reference-accessdate\">. Retrieved <span class=\"nowrap\">2015-06-25</span></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=T+cell+exclusion%2C+immune+privilege%2C+and+the+tumor+microenvironment&amp;rft.pages=74-80&amp;rft.pub=Science+Magazine&amp;rft.date=2015-04-03&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.aaa6204&amp;rft.aulast=Joyce&amp;rft.aufirst=Johanna+A.&amp;rft.au=Fearon%2C+Douglas+T.&amp;rft_id=http%3A%2F%2Fwww.sciencemag.org%2Fcontent%2F348%2F6230%2F74.full&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-physicalMicroenvironment-3\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-physicalMicroenvironment_3-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-physicalMicroenvironment_3-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-physicalMicroenvironment_3-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Spill, F.; Reynolds, D.S.; Kamm, R.D.; Zaman, M.H. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencedirect.com/science/article/pii/S0958166916300301\">\"Impact of the physical microenvironment on tumor progression and metastasis\"</a>. <i>Current Opinion in Biotechnology</i>. <b>40</b>: 41\u201348. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.copbio.2016.02.007\">10.1016/j.copbio.2016.02.007</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Biotechnology&amp;rft.atitle=Impact+of+the+physical+microenvironment+on+tumor+progression+and+metastasis&amp;rft.volume=40&amp;rft.pages=41-48&amp;rft_id=info%3Adoi%2F10.1016%2Fj.copbio.2016.02.007&amp;rft.aulast=Spill&amp;rft.aufirst=F.&amp;rft.au=Reynolds%2C+D.S.&amp;rft.au=Kamm%2C+R.D.&amp;rft.au=Zaman%2C+M.H.&amp;rft_id=http%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS0958166916300301&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Korneev, KV; Atretkhany, KN; Drutskaya, MS; Grivennikov, SI; Kuprash, DV; Nedospasov, SA (January 2017). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.sciencedirect.com/science/article/pii/S1043466616300229\">\"TLR-signaling and proinflammatory cytokines as drivers of tumorigenesis\"</a>. <i>Cytokine</i>. <b>89</b>: 127\u2013135. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.cyto.2016.01.021\">10.1016/j.cyto.2016.01.021</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/26854213\">26854213</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cytokine&amp;rft.atitle=TLR-signaling+and+proinflammatory+cytokines+as+drivers+of+tumorigenesis.&amp;rft.volume=89&amp;rft.pages=127-135&amp;rft.date=2017-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cyto.2016.01.021&amp;rft_id=info%3Apmid%2F26854213&amp;rft.aulast=Korneev&amp;rft.aufirst=KV&amp;rft.au=Atretkhany%2C+KN&amp;rft.au=Drutskaya%2C+MS&amp;rft.au=Grivennikov%2C+SI&amp;rft.au=Kuprash%2C+DV&amp;rft.au=Nedospasov%2C+SA&amp;rft_id=http%3A%2F%2Fwww.sciencedirect.com%2Fscience%2Farticle%2Fpii%2FS1043466616300229&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\">The Lancet, Volume 133, Issue 3421, 23 March 1889, Pages 571-573</span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Halachmi, E.; Witz, I.P. (1989). <a rel=\"nofollow\" class=\"external text\" href=\"http://cancerres.aacrjournals.org/content/49/9/2383.full.pdf\">\"Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Cancer Research</i>. <b>49</b> (9): 2383\u20132389<span class=\"reference-accessdate\">. Retrieved June 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Differential+tumorigenicity+of+3T3+cells+transformed+in+vitro+with+polyoma+virus+and+in+vivo+selection+for+high+tumorigenicity&amp;rft.volume=49&amp;rft.issue=9&amp;rft.pages=2383-2389&amp;rft.date=1989&amp;rft.aulast=Halachmi&amp;rft.aufirst=E.&amp;rft.au=Witz%2C+I.P.&amp;rft_id=http%3A%2F%2Fcancerres.aacrjournals.org%2Fcontent%2F49%2F9%2F2383.full.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-Witz-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Witz_7-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Witz, Isaac P.; Levy-Nissenbaum, Orlev (8 October 2006). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.canlet.2005.12.005\">\"The tumor microenvironment in the post-PAGET era\"</a>. <i>Cancer Letters</i>. <b>242</b> (1): 1\u201310. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.canlet.2005.12.005\">10.1016/j.canlet.2005.12.005</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16413116\">16413116</a><span class=\"reference-accessdate\">. Retrieved June 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Letters&amp;rft.atitle=The+tumor+microenvironment+in+the+post-PAGET+era&amp;rft.volume=242&amp;rft.issue=1&amp;rft.pages=1-10&amp;rft.date=2006-10-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.canlet.2005.12.005&amp;rft_id=info%3Apmid%2F16413116&amp;rft.aulast=Witz&amp;rft.aufirst=Isaac+P.&amp;rft.au=Levy-Nissenbaum%2C+Orlev&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.canlet.2005.12.005&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://cancer.stanford.edu/information/cancerOverview.html\">Standford Medicine Cancer Institute, Cancer Overview</a></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Duffy, Michael J. (1996). \"The biochemistry of metastasis\". <i>Advances in Clinical Chemistry</i>. <b>32</b>: 135\u2013160. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8899072\">8899072</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advances+in+Clinical+Chemistry&amp;rft.atitle=The+biochemistry+of+metastasis&amp;rft.volume=32&amp;rft.pages=135-160&amp;rft.date=1996&amp;rft_id=info%3Apmid%2F8899072&amp;rft.aulast=Duffy&amp;rft.aufirst=Michael+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-10\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Palmer, T.N.; Caride, V.J.; Caldecourt, M.A.; Twickler, J.; Abdullah, V. (1984). \"The mechanism of liposome accumulation in infarction\". <i>Biochimica et Biophysica Acta (BBA) - General Subjects</i>. <b>797</b>: 363\u2013368. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/0304-4165%2884%2990258-7\">10.1016/0304-4165(84)90258-7</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/6365177\">6365177</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta+%28BBA%29+-+General+Subjects&amp;rft.atitle=The+mechanism+of+liposome+accumulation+in+infarction&amp;rft.volume=797&amp;rft.pages=363-368&amp;rft.date=1984&amp;rft_id=info%3Adoi%2F10.1016%2F0304-4165%2884%2990258-7&amp;rft_id=info%3Apmid%2F6365177&amp;rft.aulast=Palmer&amp;rft.aufirst=T.N.&amp;rft.au=Caride%2C+V.J.&amp;rft.au=Caldecourt%2C+M.A.&amp;rft.au=Twickler%2C+J.&amp;rft.au=Abdullah%2C+V.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Danhier-11\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Danhier_11-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Danhier_11-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Danhier_11-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Danhier_11-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Danhier_11-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Danhier, Fabienne; Feron, Olivier; Pr\u00e9at, V\u00e9ronique (1 December 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.jconrel.2010.08.027\">\"To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery\"</a>. <i>Journal of Controlled Release</i>. <b>148</b> (2): 135\u2013146. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jconrel.2010.08.027\">10.1016/j.jconrel.2010.08.027</a><span class=\"reference-accessdate\">. Retrieved June 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Controlled+Release&amp;rft.atitle=To+exploit+the+tumor+microenvironment%3A+Passive+and+active+tumor+targeting+of+nanocarriers+for+anti-cancer+drug+delivery&amp;rft.volume=148&amp;rft.issue=2&amp;rft.pages=135-146&amp;rft.date=2010-12-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jconrel.2010.08.027&amp;rft.aulast=Danhier&amp;rft.aufirst=Fabienne&amp;rft.au=Feron%2C+Olivier&amp;rft.au=Pr%C3%A9at%2C+V%C3%A9ronique&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.jconrel.2010.08.027&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-Weber-12\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Weber_12-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Weber_12-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Weber_12-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Weber_12-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Weber_12-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Weber, Cynthia E.; Kuo, Paul C. (September 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.suronc.2011.09.001\">\"The tumor microenvironment\"</a>. <i>Surgical Oncology</i>. <b>21</b> (3): 172\u2013177. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.suronc.2011.09.001\">10.1016/j.suronc.2011.09.001</a><span class=\"reference-accessdate\">. Retrieved June 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Surgical+Oncology&amp;rft.atitle=The+tumor+microenvironment&amp;rft.volume=21&amp;rft.issue=3&amp;rft.pages=172-177&amp;rft.date=2012-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.suronc.2011.09.001&amp;rft.aulast=Weber&amp;rft.aufirst=Cynthia+E.&amp;rft.au=Kuo%2C+Paul+C.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.suronc.2011.09.001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-dx-13\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-dx_13-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-dx_13-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Blagosklonny, Mikhail V. (January 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/S1535-6108(03)00336-2\">\"Antiangiogenic therapy and tumor progression\"</a>. <i>Cancer Cell</i>. <b>5</b> (1): 13\u201317. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S1535-6108%2803%2900336-2\">10.1016/S1535-6108(03)00336-2</a><span class=\"reference-accessdate\">. Retrieved June 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Cell&amp;rft.atitle=Antiangiogenic+therapy+and+tumor+progression&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=13-17&amp;rft.date=2004-01&amp;rft_id=info%3Adoi%2F10.1016%2FS1535-6108%2803%2900336-2&amp;rft.aulast=Blagosklonny&amp;rft.aufirst=Mikhail+V.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2FS1535-6108%2803%2900336-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-14\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bindra, Ranjit S.; Glazer, Peter M. (6 January 2005). \"Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis\". <i>Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis</i>. <b>569</b> (1\u20132): 75\u201385. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.mrfmmm.2004.03.013\">10.1016/j.mrfmmm.2004.03.013</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15603753\">15603753</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mutation+Research%2FFundamental+and+Molecular+Mechanisms+of+Mutagenesis&amp;rft.atitle=Genetic+instability+and+the+tumor+microenvironment%3A+towards+the+concept+of+microenvironment-induced+mutagenesis&amp;rft.volume=569&amp;rft.issue=1%E2%80%932&amp;rft.pages=75-85&amp;rft.date=2005-01-06&amp;rft_id=info%3Adoi%2F10.1016%2Fj.mrfmmm.2004.03.013&amp;rft_id=info%3Apmid%2F15603753&amp;rft.aulast=Bindra&amp;rft.aufirst=Ranjit+S.&amp;rft.au=Glazer%2C+Peter+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gatenby, Robert A.; Gillies, Robert J. (November 2004). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1038/nrc1478\">\"Why do cancers have high aerobic glycolysis?\"</a>. <i>Nature Reviews Cancer</i>. <b>4</b> (11): 891\u2013899. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrc1478\">10.1038/nrc1478</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15516961\">15516961</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Cancer&amp;rft.atitle=Why+do+cancers+have+high+aerobic+glycolysis%3F&amp;rft.volume=4&amp;rft.issue=11&amp;rft.pages=891-899&amp;rft.date=2004-11&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc1478&amp;rft_id=info%3Apmid%2F15516961&amp;rft.aulast=Gatenby&amp;rft.aufirst=Robert+A.&amp;rft.au=Gillies%2C+Robert+J.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1038%2Fnrc1478&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sluis, Robert van; Bhujwalla, Zaver M.; Raghunand, Natarajan; Ballesteros, Paloma; Alvarez, Jos\u00e9; Cerd\u00e1n, Sebasti\u00e1n; Galons, Jean-Philippe; Gillies, Robert J. (April 1999). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1002/(SICI)1522-2594(199904)41:4\">&lt;743::AID-MRM13&gt;3.0.CO;2-Z \"In vivo imaging of extracellular pH using 1H MRSI\"</a>. <i>Magnetic Resonance in Medicine</i>. <b>41</b> (4): 743\u2013750. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/%28SICI%291522-2594%28199904%2941%3A4%3C743%3A%3AAID-MRM13%3E3.0.CO%3B2-Z\">10.1002/(SICI)1522-2594(199904)41:4&#60;743::AID-MRM13&#62;3.0.CO;2-Z</a><span class=\"reference-accessdate\">. Retrieved June 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Magnetic+Resonance+in+Medicine&amp;rft.atitle=In+vivo+imaging+of+extracellular+pH+using+1H+MRSI&amp;rft.volume=41&amp;rft.issue=4&amp;rft.pages=743-750&amp;rft.date=1999-04&amp;rft_id=info%3Adoi%2F10.1002%2F%28SICI%291522-2594%28199904%2941%3A4%3C743%3A%3AAID-MRM13%3E3.0.CO%3B2-Z&amp;rft.aulast=Sluis&amp;rft.aufirst=Robert+van&amp;rft.au=Bhujwalla%2C+Zaver+M.&amp;rft.au=Raghunand%2C+Natarajan&amp;rft.au=Ballesteros%2C+Paloma&amp;rft.au=Alvarez%2C+Jos%C3%A9&amp;rft.au=Cerd%C3%A1n%2C+Sebasti%C3%A1n&amp;rft.au=Galons%2C+Jean-Philippe&amp;rft.au=Gillies%2C+Robert+J.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1002%2F%28SICI%291522-2594%28199904%2941%3A4%3C743%3A%3AAID-MRM13%3E3.0.CO%3B2-Z&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Estrella, Veronica; Chen, Tingan; Lloyd, Mark; Wojtkowiak, Jonathan; Cornnell, Heather H.; Ibrahim-Hashim, Arig; Bailey, Kate; Balagurunathan, Yoganand; Rothberg, Jennifer M.; Sloane, Bonnie F.; Johnson, Joseph; Gatenby, Robert A.; Gillies, Robert J. (1 March 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1158/0008-5472.CAN-12-2796\">\"Acidity Generated by the Tumor Microenvironment Drives Local Invasion\"</a>. <i>Cancer Research</i>. <b>73</b> (5): 1524\u20131535. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1158/0008-5472.CAN-12-2796\">10.1158/0008-5472.CAN-12-2796</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3594450\">3594450</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/23288510\">23288510</a><span class=\"reference-accessdate\">. Retrieved June 2015</span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Acidity+Generated+by+the+Tumor+Microenvironment+Drives+Local+Invasion&amp;rft.volume=73&amp;rft.issue=5&amp;rft.pages=1524-1535&amp;rft.date=2013-03-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3594450&amp;rft_id=info%3Apmid%2F23288510&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-12-2796&amp;rft.aulast=Estrella&amp;rft.aufirst=Veronica&amp;rft.au=Chen%2C+Tingan&amp;rft.au=Lloyd%2C+Mark&amp;rft.au=Wojtkowiak%2C+Jonathan&amp;rft.au=Cornnell%2C+Heather+H.&amp;rft.au=Ibrahim-Hashim%2C+Arig&amp;rft.au=Bailey%2C+Kate&amp;rft.au=Balagurunathan%2C+Yoganand&amp;rft.au=Rothberg%2C+Jennifer+M.&amp;rft.au=Sloane%2C+Bonnie+F.&amp;rft.au=Johnson%2C+Joseph&amp;rft.au=Gatenby%2C+Robert+A.&amp;rft.au=Gillies%2C+Robert+J.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1158%2F0008-5472.CAN-12-2796&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span> <span style=\"font-size:100%\" class=\"error citation-comment\">Check date values in: <code style=\"color:inherit; border:inherit; padding:inherit;\">&#124;accessdate=</code> (<a href=\"/wiki/Help:CS1_errors#bad_date\" title=\"Help:CS1 errors\">help</a>)</span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Dvorak, Harold F. (25 December 1986). \"Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing\". <i>New England Journal of Medicine</i>. <b>325</b> (26): 1650\u20131659. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1056/NEJM198612253152606\">10.1056/NEJM198612253152606</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=New+England+Journal+of+Medicine&amp;rft.atitle=Tumors%3A+wounds+that+do+not+heal.+Similarities+between+tumor+stroma+generation+and+wound+healing&amp;rft.volume=325&amp;rft.issue=26&amp;rft.pages=1650-1659&amp;rft.date=1986-12-25&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM198612253152606&amp;rft.aulast=Dvorak&amp;rft.aufirst=Harold+F.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kundu, Joydeb Kumar; Surh, Young-Joon (July\u2013August 2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.mrrev.2008.03.002\">\"Inflammation: Gearing the journey to cancer\"</a>. <i>Mutation Research/Reviews in Mutation Research</i>. <b>659</b> (1\u20132): 15\u201330. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.mrrev.2008.03.002\">10.1016/j.mrrev.2008.03.002</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mutation+Research%2FReviews+in+Mutation+Research&amp;rft.atitle=Inflammation%3A+Gearing+the+journey+to+cancer&amp;rft.volume=659&amp;rft.issue=1%E2%80%932&amp;rft.pages=15-30&amp;rft.date=2008-07%2F2008-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.mrrev.2008.03.002&amp;rft.aulast=Kundu&amp;rft.aufirst=Joydeb+Kumar&amp;rft.au=Surh%2C+Young-Joon&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.mrrev.2008.03.002&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Hanahan-20\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Hanahan_20-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Hanahan_20-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Hanahan_20-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hanahan, Douglas; Coussens, Lisa M. (20 March 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.ccr.2012.02.022\">\"Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment\"</a>. <i>Cancer Cell</i>. <b>21</b> (3): 309\u2013322. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ccr.2012.02.022\">10.1016/j.ccr.2012.02.022</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22439926\">22439926</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Cell&amp;rft.atitle=Accessories+to+the+Crime%3A+Functions+of+Cells+Recruited+to+the+Tumor+Microenvironment&amp;rft.volume=21&amp;rft.issue=3&amp;rft.pages=309-322&amp;rft.date=2012-03-20&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccr.2012.02.022&amp;rft_id=info%3Apmid%2F22439926&amp;rft.aulast=Hanahan&amp;rft.aufirst=Douglas&amp;rft.au=Coussens%2C+Lisa+M.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.ccr.2012.02.022&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">R\u00e4s\u00e4nen, Kati; Vaheri, Antti (15 October 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.yexcr.2010.04.032\">\"Activation of fibroblasts in cancer stroma\"</a>. <i>Experimental Cell Research</i>. <b>316</b> (17): 2713\u20132722. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.yexcr.2010.04.032\">10.1016/j.yexcr.2010.04.032</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Experimental+Cell+Research&amp;rft.atitle=Activation+of+fibroblasts+in+cancer+stroma&amp;rft.volume=316&amp;rft.issue=17&amp;rft.pages=2713-2722&amp;rft.date=2010-10-15&amp;rft_id=info%3Adoi%2F10.1016%2Fj.yexcr.2010.04.032&amp;rft.aulast=R%C3%A4s%C3%A4nen&amp;rft.aufirst=Kati&amp;rft.au=Vaheri%2C+Antti&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.yexcr.2010.04.032&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Marsh-22\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Marsh_22-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Marsh_22-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Marsh_22-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Marsh, Timothy; Pietras, Kristian; McAllister, Sandra S. (30 October 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.bbadis.2012.10.013\">\"Fibroblasts as architects of cancer pathogenesis\"</a>. <i>Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</i>. <b>1832</b>: 1070\u20131078. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bbadis.2012.10.013\">10.1016/j.bbadis.2012.10.013</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biochimica+et+Biophysica+Acta+%28BBA%29+-+Molecular+Basis+of+Disease&amp;rft.atitle=Fibroblasts+as+architects+of+cancer+pathogenesis&amp;rft.volume=1832&amp;rft.pages=1070-1078&amp;rft.date=2012-10-30&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bbadis.2012.10.013&amp;rft.aulast=Marsh&amp;rft.aufirst=Timothy&amp;rft.au=Pietras%2C+Kristian&amp;rft.au=McAllister%2C+Sandra+S.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.bbadis.2012.10.013&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-23\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Quant, Michael; Shui Ping, Tu; Tomita, Hiroyuki; Gonda, Tamas; Wang, Sophie S.W.; Takashi, Shigeo; Baik, Gwang Ho; Shibata, Wataru; DiPrete, Bethany; Betz, Kelly S.; Friedman, Richard; Varro, Andrea; Tycko, Benjamin; Wang, Timothy C. (15 February 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.ccr.2011.01.020\">\"Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth\"</a>. <i>Cancer Cell</i>. <b>19</b> (2): 257\u2013272. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ccr.2011.01.020\">10.1016/j.ccr.2011.01.020</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3060401\">3060401</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21316604\">21316604</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Cell&amp;rft.atitle=Bone+Marrow-Derived+Myofibroblasts+Contribute+to+the+Mesenchymal+Stem+Cell+Niche+and+Promote+Tumor+Growth&amp;rft.volume=19&amp;rft.issue=2&amp;rft.pages=257-272&amp;rft.date=2011-02-15&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3060401&amp;rft_id=info%3Apmid%2F21316604&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccr.2011.01.020&amp;rft.aulast=Quant&amp;rft.aufirst=Michael&amp;rft.au=Shui+Ping%2C+Tu&amp;rft.au=Tomita%2C+Hiroyuki&amp;rft.au=Gonda%2C+Tamas&amp;rft.au=Wang%2C+Sophie+S.W.&amp;rft.au=Takashi%2C+Shigeo&amp;rft.au=Baik%2C+Gwang+Ho&amp;rft.au=Shibata%2C+Wataru&amp;rft.au=DiPrete%2C+Bethany&amp;rft.au=Betz%2C+Kelly+S.&amp;rft.au=Friedman%2C+Richard&amp;rft.au=Varro%2C+Andrea&amp;rft.au=Tycko%2C+Benjamin&amp;rft.au=Wang%2C+Timothy+C.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.ccr.2011.01.020&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Flaberg, Emilie; Markasz, Laszlo; Petranyi, Gabor; Stuber, Gyorgy; Dics\u0151, Ferenc; Alchihabi, Nidal; Ol\u00e1h, Eva; Cs\u00edzy, Istv\u00e1n; J\u00f3zsa, Tam\u00e1s; Andr\u00e9n, Ove; Johansson, Jan-Erik; Andersson, Swen-Olof; Klein, George; Szekely, Laszlo (29 December 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1002/ijc.25612\">\"High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts\"</a>. <i>Cancer Cell Biology</i>. <b>128</b>: 2793\u20132802. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/ijc.25612\">10.1002/ijc.25612</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Cell+Biology&amp;rft.atitle=%3C%2Ffont%3EHigh-throughput+live-cell+imaging+reveals+differential+inhibition+of+tumor+cell+proliferation+by+human+fibroblasts&amp;rft.volume=128&amp;rft.pages=2793-2802&amp;rft.date=2010-12-29&amp;rft_id=info%3Adoi%2F10.1002%2Fijc.25612&amp;rft.aulast=Flaberg&amp;rft.aufirst=Emilie&amp;rft.au=Markasz%2C+Laszlo&amp;rft.au=Petranyi%2C+Gabor&amp;rft.au=Stuber%2C+Gyorgy&amp;rft.au=Dics%C5%91%2C+Ferenc&amp;rft.au=Alchihabi%2C+Nidal&amp;rft.au=Ol%C3%A1h%2C+Eva&amp;rft.au=Cs%C3%ADzy%2C+Istv%C3%A1n&amp;rft.au=J%C3%B3zsa%2C+Tam%C3%A1s&amp;rft.au=Andr%C3%A9n%2C+Ove&amp;rft.au=Johansson%2C+Jan-Erik&amp;rft.au=Andersson%2C+Swen-Olof&amp;rft.au=Klein%2C+George&amp;rft.au=Szekely%2C+Laszlo&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1002%2Fijc.25612&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-25\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Chaffer, Christine L.; Weinberg, Robert A. (25 March 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1126/science.1203543\">\"A Perspective on Cancer Cell Metastasis\"</a>. <i>Science</i>. <b>331</b> (6024): 1559\u20131564. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.1203543\">10.1126/science.1203543</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21436443\">21436443</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=A+Perspective+on+Cancer+Cell+Metastasis&amp;rft.volume=331&amp;rft.issue=6024&amp;rft.pages=1559-1564&amp;rft.date=2011-03-25&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.1203543&amp;rft_id=info%3Apmid%2F21436443&amp;rft.aulast=Chaffer&amp;rft.aufirst=Christine+L.&amp;rft.au=Weinberg%2C+Robert+A.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1126%2Fscience.1203543&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-26\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Stover, Daniel G.; Bierie, Brian; Moses, Harold L. (July 2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1002/jcb.21149\">\"A delicate balance: TGF-\u03b2 and the tumor microenvironment\"</a>. <i>Journal of Cellular Biochemistry</i>. <b>101</b> (4): 851\u2013861. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/jcb.21149\">10.1002/jcb.21149</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Cellular+Biochemistry&amp;rft.atitle=A+delicate+balance%3A+TGF-%CE%B2+and+the+tumor+microenvironment&amp;rft.volume=101&amp;rft.issue=4&amp;rft.pages=851-861&amp;rft.date=2007-07&amp;rft_id=info%3Adoi%2F10.1002%2Fjcb.21149&amp;rft.aulast=Stover&amp;rft.aufirst=Daniel+G.&amp;rft.au=Bierie%2C+Brian&amp;rft.au=Moses%2C+Harold+L.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1002%2Fjcb.21149&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Bronte-27\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Bronte_27-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Bronte_27-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bronte, Vincenzo; Gabrilovich, Dmitry. <a rel=\"nofollow\" class=\"external text\" href=\"http://www.nature.com/nri/posters/mdscs/nri1005_mdscs_poster.pdf\">\"Myeloid-derived suppressor cells (Poster)\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Nature</i>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Myeloid-derived+suppressor+cells+%28Poster%29&amp;rft.aulast=Bronte&amp;rft.aufirst=Vincenzo&amp;rft.au=Gabrilovich%2C+Dmitry&amp;rft_id=http%3A%2F%2Fwww.nature.com%2Fnri%2Fposters%2Fmdscs%2Fnri1005_mdscs_poster.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mantovani, Alberto; Allavena, Paola; Sica, Antonio; Balkwill, Frances (Jul 2008). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1038/nature07205\">\"Cancer-related inflammation\"</a>. <i>Nature</i>. <b>454</b>: 436\u201344. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nature07205\">10.1038/nature07205</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18650914\">18650914</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Cancer-related+inflammation&amp;rft.volume=454&amp;rft.pages=436-44&amp;rft.date=2008-07&amp;rft_id=info%3Adoi%2F10.1038%2Fnature07205&amp;rft_id=info%3Apmid%2F18650914&amp;rft.aulast=Mantovani&amp;rft.aufirst=Alberto&amp;rft.au=Allavena%2C+Paola&amp;rft.au=Sica%2C+Antonio&amp;rft.au=Balkwill%2C+Frances&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1038%2Fnature07205&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Mathias-29\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Mathias_29-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Mathias_29-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mathias, Rommel A.; Gopal, Shashi K.; Simpson, Richard J. (14 January 2013). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.jprot.2012.10.016\">\"Contribution of cells undergoing epithelial\u2013mesenchymal transition to the tumour microenvironment\"</a>. <i>Journal of Proteomics</i>. <b>78</b>: 545\u2013557. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.jprot.2012.10.016\">10.1016/j.jprot.2012.10.016</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Proteomics&amp;rft.atitle=Contribution+of+cells+undergoing+epithelial%E2%80%93mesenchymal+transition+to+the+tumour+microenvironment&amp;rft.volume=78&amp;rft.pages=545-557&amp;rft.date=2013-01-14&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jprot.2012.10.016&amp;rft.aulast=Mathias&amp;rft.aufirst=Rommel+A.&amp;rft.au=Gopal%2C+Shashi+K.&amp;rft.au=Simpson%2C+Richard+J.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.jprot.2012.10.016&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Valenti-30\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Valenti_30-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Valenti_30-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Valenti, Roberta; Huber, Veronica; Iero, Manuela; Filipazzi, Paola; Parmiani, Giorgio; Rivoltini, Licia (1 April 2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1158/0008-5472.CAN-07-0520\">\"Tumor-released microvesicles as vehicles of immunosuppression\"</a>. <i>Cancer Research</i>. <b>67</b>: 2912\u20131915. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1158/0008-5472.CAN-07-0520\">10.1158/0008-5472.CAN-07-0520</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/17409393\">17409393</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Tumor-released+microvesicles+as+vehicles+of+immunosuppression&amp;rft.volume=67&amp;rft.pages=2912-1915&amp;rft.date=2007-04-01&amp;rft_id=info%3Adoi%2F10.1158%2F0008-5472.CAN-07-0520&amp;rft_id=info%3Apmid%2F17409393&amp;rft.aulast=Valenti&amp;rft.aufirst=Roberta&amp;rft.au=Huber%2C+Veronica&amp;rft.au=Iero%2C+Manuela&amp;rft.au=Filipazzi%2C+Paola&amp;rft.au=Parmiani%2C+Giorgio&amp;rft.au=Rivoltini%2C+Licia&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1158%2F0008-5472.CAN-07-0520&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Balkwill, Frances; Charles, Kellie A.; Mantovani, Alberto. <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.ccr.2005.02.013\">\"Smoldering and polarized inflammation in the initiation and promotion of malignant disease\"</a>. <i>Cancer Cell</i>. <b>7</b> (3, March 2005): 211\u2013217. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ccr.2005.02.013\">10.1016/j.ccr.2005.02.013</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15766659\">15766659</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Cell&amp;rft.atitle=Smoldering+and+polarized+inflammation+in+the+initiation+and+promotion+of+malignant+disease&amp;rft.volume=7&amp;rft.issue=3%2C+March+2005&amp;rft.pages=211-217&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccr.2005.02.013&amp;rft_id=info%3Apmid%2F15766659&amp;rft.aulast=Balkwill&amp;rft.aufirst=Frances&amp;rft.au=Charles%2C+Kellie+A.&amp;rft.au=Mantovani%2C+Alberto&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.ccr.2005.02.013&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Qian, Bin-Zhi; Pollard, Jeffrey W. (2 April 2010). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.cell.2010.03.014\">\"Macrophage Diversity Enhances Tumor Progression and Metastasis\"</a>. <i>Cell</i>. <b>141</b> (1): 39\u201351. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.cell.2010.03.014\">10.1016/j.cell.2010.03.014</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4994190\">4994190</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20371344\">20371344</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=Macrophage+Diversity+Enhances+Tumor+Progression+and+Metastasis&amp;rft.volume=141&amp;rft.issue=1&amp;rft.pages=39-51&amp;rft.date=2010-04-02&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4994190&amp;rft_id=info%3Apmid%2F20371344&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cell.2010.03.014&amp;rft.aulast=Qian&amp;rft.aufirst=Bin-Zhi&amp;rft.au=Pollard%2C+Jeffrey+W.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.cell.2010.03.014&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Solinas-33\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Solinas_33-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Solinas_33-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Solinas_33-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Solinas, G.; Germano, G.; Mantovani, A.; Allavena, P. (November 2009). <a rel=\"nofollow\" class=\"external text\" href=\"http://www.jleukbio.org/content/86/5/1065\">\"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation\"</a>. <i>Journal of Leukocyte Biology</i>. <b>86</b> (5): 1065\u20131073. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1189/jlb.0609385\">10.1189/jlb.0609385</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Leukocyte+Biology&amp;rft.atitle=Tumor-associated+macrophages+%28TAM%29+as+major+players+of+the+cancer-related+inflammation&amp;rft.volume=86&amp;rft.issue=5&amp;rft.pages=1065-1073&amp;rft.date=2009-11&amp;rft_id=info%3Adoi%2F10.1189%2Fjlb.0609385&amp;rft.aulast=Solinas&amp;rft.aufirst=G.&amp;rft.au=Germano%2C+G.&amp;rft.au=Mantovani%2C+A.&amp;rft.au=Allavena%2C+P.&amp;rft_id=http%3A%2F%2Fwww.jleukbio.org%2Fcontent%2F86%2F5%2F1065&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Biswas, Subhra K.; Gangi, Lisa; Paul, Saki; Schioppa, Tiziana; Saccani, Alessandra; Sironi, Marina; Bottazzi, Barbara; Doni, Andrea; Vincenzo, Bronte; Pasqualini, Fabio; Vago, Luca; Nebuloni, Manuela; Mantovani, Alberto; Sica, Antonio (3 November 2005). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1182/blood-2005-01-0428\">\"A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-\u03baB and enhanced IRF-3/STAT1 activation)\"</a>. <i>Blood</i>. <b>107</b> (5): 2112\u20132122. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1182/blood-2005-01-0428\">10.1182/blood-2005-01-0428</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16269622\">16269622</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood&amp;rft.atitle=A+distinct+and+unique+transcriptional+program+expressed+by+tumor-associated+macrophages+%28defective+NF-%CE%BAB+and+enhanced+IRF-3%2FSTAT1+activation%29&amp;rft.volume=107&amp;rft.issue=5&amp;rft.pages=2112-2122&amp;rft.date=2005-11-03&amp;rft_id=info%3Adoi%2F10.1182%2Fblood-2005-01-0428&amp;rft_id=info%3Apmid%2F16269622&amp;rft.aulast=Biswas&amp;rft.aufirst=Subhra+K.&amp;rft.au=Gangi%2C+Lisa&amp;rft.au=Paul%2C+Saki&amp;rft.au=Schioppa%2C+Tiziana&amp;rft.au=Saccani%2C+Alessandra&amp;rft.au=Sironi%2C+Marina&amp;rft.au=Bottazzi%2C+Barbara&amp;rft.au=Doni%2C+Andrea&amp;rft.au=Vincenzo%2C+Bronte&amp;rft.au=Pasqualini%2C+Fabio&amp;rft.au=Vago%2C+Luca&amp;rft.au=Nebuloni%2C+Manuela&amp;rft.au=Mantovani%2C+Alberto&amp;rft.au=Sica%2C+Antonio&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1182%2Fblood-2005-01-0428&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zhang, Wei; Wang, Liang; Zhou, Daobin; Cui, Quancai; Zhao, Dachun; Wu, Yongji (January 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.3109/10428194.2010.529204\">\"Expression of tumor-associated macrophages and vascular endothelial growth factor correlates with poor prognosis of peripheral T-cell lymphoma, not otherwise specified\"</a>. <i>Leukemia and Lymphoma</i>. <b>52</b> (1): 46\u201352. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3109/10428194.2010.529204\">10.3109/10428194.2010.529204</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Leukemia+and+Lymphoma&amp;rft.atitle=Expression+of+tumor-associated+macrophages+and+vascular+endothelial+growth+factor+correlates+with+poor+prognosis+of+peripheral+T-cell+lymphoma%2C+not+otherwise+specified&amp;rft.volume=52&amp;rft.issue=1&amp;rft.pages=46-52&amp;rft.date=2011-01&amp;rft_id=info%3Adoi%2F10.3109%2F10428194.2010.529204&amp;rft.aulast=Zhang&amp;rft.aufirst=Wei&amp;rft.au=Wang%2C+Liang&amp;rft.au=Zhou%2C+Daobin&amp;rft.au=Cui%2C+Quancai&amp;rft.au=Zhao%2C+Dachun&amp;rft.au=Wu%2C+Yongji&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.3109%2F10428194.2010.529204&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Zhang, Bi Cheng; Gao, Juan; Wang, Jun; Rao, Zhi Guo; Cheng Wang,, Bao; Gao, Jian Fei (December 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1007/s12032-010-9638-5\">\"Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma\"</a>. <i>Medical Oncology</i>. <b>28</b> (4): 1447\u20131452. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1007/s12032-010-9638-5\">10.1007/s12032-010-9638-5</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medical+Oncology&amp;rft.atitle=Tumor-associated+macrophages+infiltration+is+associated+with+peritumoral+lymphangiogenesis+and+poor+prognosis+in+lung+adenocarcinoma&amp;rft.volume=28&amp;rft.issue=4&amp;rft.pages=1447-1452&amp;rft.date=2011-12&amp;rft_id=info%3Adoi%2F10.1007%2Fs12032-010-9638-5&amp;rft.aulast=Zhang&amp;rft.aufirst=Bi+Cheng&amp;rft.au=Gao%2C+Juan&amp;rft.au=Wang%2C+Jun&amp;rft.au=Rao%2C+Zhi+Guo&amp;rft.au=Cheng+Wang%2C%2C+Bao&amp;rft.au=Gao%2C+Jian+Fei&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1007%2Fs12032-010-9638-5&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-37\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-37\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yang, Mei; Chen, Jingqi; Su, Fang; Yu, Bin; Su, Fengxi; Lin, Ling; Liu, Yujie; Huan, Jian-Dong; Song, Erwei (22 September 2011). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1186/1476-4598-10-117\">\"Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells\"</a>. <i>Molecular Cancer</i>. <b>10</b> (117). <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/1476-4598-10-117\">10.1186/1476-4598-10-117</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3190352\">3190352</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21939504\">21939504</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+Cancer&amp;rft.atitle=Microvesicles+secreted+by+macrophages+shuttle+invasion-potentiating+microRNAs+into+breast+cancer+cells&amp;rft.volume=10&amp;rft.issue=117&amp;rft.date=2011-09-22&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3190352&amp;rft_id=info%3Apmid%2F21939504&amp;rft_id=info%3Adoi%2F10.1186%2F1476-4598-10-117&amp;rft.aulast=Yang&amp;rft.aufirst=Mei&amp;rft.au=Chen%2C+Jingqi&amp;rft.au=Su%2C+Fang&amp;rft.au=Yu%2C+Bin&amp;rft.au=Su%2C+Fengxi&amp;rft.au=Lin%2C+Ling&amp;rft.au=Liu%2C+Yujie&amp;rft.au=Huan%2C+Jian-Dong&amp;rft.au=Song%2C+Erwei&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1186%2F1476-4598-10-117&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-38\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-38\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Coffelt, Seth B.; Wellenstein, Max D.; de Visser, Karin E. (10 June 2016). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.nature.com/articles/nrc.2016.52\">\"Neutrophils in cancer: neutral no more\"</a>. <i>Nature Reviews Cancer</i>. <b>16</b> (7): 431\u2013446. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrc.2016.52\">10.1038/nrc.2016.52</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27282249\">27282249</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Cancer&amp;rft.atitle=Neutrophils+in+cancer%3A+neutral+no+more&amp;rft.volume=16&amp;rft.issue=7&amp;rft.pages=431-446&amp;rft.date=2016-06-10&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc.2016.52&amp;rft_id=info%3Apmid%2F27282249&amp;rft.aulast=Coffelt&amp;rft.aufirst=Seth+B.&amp;rft.au=Wellenstein%2C+Max+D.&amp;rft.au=de+Visser%2C+Karin+E.&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fnrc.2016.52&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-39\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-39\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gentles, Andrew J; Newman, Aaron M; Liu, Chih Long; Bratman, Scott V; Feng, Weiguo; Kim, Dongkyoon; Nair, Viswam S; Xu, Yue; Khuong, Amanda; Hoang, Chuong D; Diehn, Maximilian; West, Robert B; Plevritis, Sylvia K; Alizadeh, Ash A (20 July 2015). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4852857\">\"The prognostic landscape of genes and infiltrating immune cells across human cancers\"</a>. <i>Nature Medicine</i>. <b>21</b> (8): 938\u2013945. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nm.3909\">10.1038/nm.3909</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4852857\">4852857</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Medicine&amp;rft.atitle=The+prognostic+landscape+of+genes+and+infiltrating+immune+cells+across+human+cancers&amp;rft.volume=21&amp;rft.issue=8&amp;rft.pages=938-945&amp;rft.date=2015-07-20&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4852857&amp;rft_id=info%3Adoi%2F10.1038%2Fnm.3909&amp;rft.aulast=Gentles&amp;rft.aufirst=Andrew+J&amp;rft.au=Newman%2C+Aaron+M&amp;rft.au=Liu%2C+Chih+Long&amp;rft.au=Bratman%2C+Scott+V&amp;rft.au=Feng%2C+Weiguo&amp;rft.au=Kim%2C+Dongkyoon&amp;rft.au=Nair%2C+Viswam+S&amp;rft.au=Xu%2C+Yue&amp;rft.au=Khuong%2C+Amanda&amp;rft.au=Hoang%2C+Chuong+D&amp;rft.au=Diehn%2C+Maximilian&amp;rft.au=West%2C+Robert+B&amp;rft.au=Plevritis%2C+Sylvia+K&amp;rft.au=Alizadeh%2C+Ash+A&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4852857&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-40\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-40\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Engblom, Camilla; Pfirschke, Christina; Pittet, Mikael J. (1 July 2016). \"The role of myeloid cells in cancer therapies\". <i>Nature Reviews Cancer</i>. <b>16</b> (7): 447\u2013462. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrc.2016.54\">10.1038/nrc.2016.54</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Cancer&amp;rft.atitle=The+role+of+myeloid+cells+in+cancer+therapies&amp;rft.volume=16&amp;rft.issue=7&amp;rft.pages=447-462&amp;rft.date=2016-07-01&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc.2016.54&amp;rft.aulast=Engblom&amp;rft.aufirst=Camilla&amp;rft.au=Pfirschke%2C+Christina&amp;rft.au=Pittet%2C+Mikael+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-41\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-41\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Huang, Shao Hui; Waldron, John N.; Milosevic, Michael; Shen, Xiaowei; Ringash, Jolie; Su, Jie; Tong, Li; Perez-Ordonez, Bayardo; Weinreb, Ilan; Bayley, Andrew J.; Kim, John; Hope, Andrew; Cho, B.C. John; Giuliani, Meredith; Razak, Albiruni; Goldstein, David; Shi, Willa; Liu, Fei-Fei; Xu, Wei; O'Sullivan, Brian (15 February 2015). \"Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status\". <i>Cancer</i>. <b>121</b> (4): 545\u2013555. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/cncr.29100\">10.1002/cncr.29100</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer&amp;rft.atitle=Prognostic+value+of+pretreatment+circulating+neutrophils%2C+monocytes%2C+and+lymphocytes+in+oropharyngeal+cancer+stratified+by+human+papillomavirus+status&amp;rft.volume=121&amp;rft.issue=4&amp;rft.pages=545-555&amp;rft.date=2015-02-15&amp;rft_id=info%3Adoi%2F10.1002%2Fcncr.29100&amp;rft.aulast=Huang&amp;rft.aufirst=Shao+Hui&amp;rft.au=Waldron%2C+John+N.&amp;rft.au=Milosevic%2C+Michael&amp;rft.au=Shen%2C+Xiaowei&amp;rft.au=Ringash%2C+Jolie&amp;rft.au=Su%2C+Jie&amp;rft.au=Tong%2C+Li&amp;rft.au=Perez-Ordonez%2C+Bayardo&amp;rft.au=Weinreb%2C+Ilan&amp;rft.au=Bayley%2C+Andrew+J.&amp;rft.au=Kim%2C+John&amp;rft.au=Hope%2C+Andrew&amp;rft.au=Cho%2C+B.C.+John&amp;rft.au=Giuliani%2C+Meredith&amp;rft.au=Razak%2C+Albiruni&amp;rft.au=Goldstein%2C+David&amp;rft.au=Shi%2C+Willa&amp;rft.au=Liu%2C+Fei-Fei&amp;rft.au=Xu%2C+Wei&amp;rft.au=O%27Sullivan%2C+Brian&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-42\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-42\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jiang, Long; Jiang, Shanshan; Situ, Dongrong; Lin, Yongbin; Yang, Han; Li, Yuanfang; Long, Hao; Zhou, Zhiwei (24 March 2015). \"Prognostic value of monocyte and neutrophils to lymphocytes ratio in patients with metastatic soft tissue sarcoma\". <i>Oncotarget</i>. <b>6</b> (11). <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.18632/oncotarget.3283\">10.18632/oncotarget.3283</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Oncotarget&amp;rft.atitle=Prognostic+value+of+monocyte+and+neutrophils+to+lymphocytes+ratio+in+patients+with+metastatic+soft+tissue+sarcoma&amp;rft.volume=6&amp;rft.issue=11&amp;rft.date=2015-03-24&amp;rft_id=info%3Adoi%2F10.18632%2Foncotarget.3283&amp;rft.aulast=Jiang&amp;rft.aufirst=Long&amp;rft.au=Jiang%2C+Shanshan&amp;rft.au=Situ%2C+Dongrong&amp;rft.au=Lin%2C+Yongbin&amp;rft.au=Yang%2C+Han&amp;rft.au=Li%2C+Yuanfang&amp;rft.au=Long%2C+Hao&amp;rft.au=Zhou%2C+Zhiwei&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-43\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-43\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wu, W.-C.; Sun, H.-W.; Chen, H.-T.; Liang, J.; Yu, X.-J.; Wu, C.; Wang, Z.; Zheng, L. (3 March 2014). \"Circulating hematopoietic stem and progenitor cells are myeloid-biased in cancer patients\". <i>Proceedings of the National Academy of Sciences</i>. <b>111</b> (11): 4221\u20134226. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.1320753111\">10.1073/pnas.1320753111</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences&amp;rft.atitle=Circulating+hematopoietic+stem+and+progenitor+cells+are+myeloid-biased+in+cancer+patients&amp;rft.volume=111&amp;rft.issue=11&amp;rft.pages=4221-4226&amp;rft.date=2014-03-03&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.1320753111&amp;rft.aulast=Wu&amp;rft.aufirst=W.-C.&amp;rft.au=Sun%2C+H.-W.&amp;rft.au=Chen%2C+H.-T.&amp;rft.au=Liang%2C+J.&amp;rft.au=Yu%2C+X.-J.&amp;rft.au=Wu%2C+C.&amp;rft.au=Wang%2C+Z.&amp;rft.au=Zheng%2C+L.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-44\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-44\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Faget, Julien; Groeneveld, Svenja; Boivin, Gael; Sankar, Martial; Zangger, Nadine; Garcia, Miguel; Guex, Nicolas; Zlobec, Inti; Steiner, Lo\u00efc; Piersigilli, Alessandra; Xenarios, Ioannis; Meylan, Etienne (December 2017). \"Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer\". <i>Cell Reports</i>. <b>21</b> (11): 3190\u20133204. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.celrep.2017.11.052\">10.1016/j.celrep.2017.11.052</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell+Reports&amp;rft.atitle=Neutrophils+and+Snail+Orchestrate+the+Establishment+of+a+Pro-tumor+Microenvironment+in+Lung+Cancer&amp;rft.volume=21&amp;rft.issue=11&amp;rft.pages=3190-3204&amp;rft.date=2017-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.celrep.2017.11.052&amp;rft.aulast=Faget&amp;rft.aufirst=Julien&amp;rft.au=Groeneveld%2C+Svenja&amp;rft.au=Boivin%2C+Gael&amp;rft.au=Sankar%2C+Martial&amp;rft.au=Zangger%2C+Nadine&amp;rft.au=Garcia%2C+Miguel&amp;rft.au=Guex%2C+Nicolas&amp;rft.au=Zlobec%2C+Inti&amp;rft.au=Steiner%2C+Lo%C3%AFc&amp;rft.au=Piersigilli%2C+Alessandra&amp;rft.au=Xenarios%2C+Ioannis&amp;rft.au=Meylan%2C+Etienne&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-45\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-45\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Coffelt, Seth B.; Kersten, Kelly; Doornebal, Chris W.; Weiden, Jorieke; Vrijland, Kim; Hau, Cheei-Sing; Verstegen, Niels J. M.; Ciampricotti, Metamia; Hawinkels, Lukas J. A. C.; Jonkers, Jos; de Visser, Karin E. (30 March 2015). \"IL-17-producing \u03b3\u03b4 T cells and neutrophils conspire to promote breast cancer metastasis\". <i>Nature</i>. <b>522</b> (7556): 345\u2013348. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nature14282\">10.1038/nature14282</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=IL-17-producing+%CE%B3%CE%B4+T+cells+and+neutrophils+conspire+to+promote+breast+cancer+metastasis&amp;rft.volume=522&amp;rft.issue=7556&amp;rft.pages=345-348&amp;rft.date=2015-03-30&amp;rft_id=info%3Adoi%2F10.1038%2Fnature14282&amp;rft.aulast=Coffelt&amp;rft.aufirst=Seth+B.&amp;rft.au=Kersten%2C+Kelly&amp;rft.au=Doornebal%2C+Chris+W.&amp;rft.au=Weiden%2C+Jorieke&amp;rft.au=Vrijland%2C+Kim&amp;rft.au=Hau%2C+Cheei-Sing&amp;rft.au=Verstegen%2C+Niels+J.+M.&amp;rft.au=Ciampricotti%2C+Metamia&amp;rft.au=Hawinkels%2C+Lukas+J.+A.+C.&amp;rft.au=Jonkers%2C+Jos&amp;rft.au=de+Visser%2C+Karin+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-46\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-46\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Engblom, Camilla; Pfirschke, Christina; Zilionis, Rapolas; Da Silva Martins, Janaina; Bos, Stijn A.; Courties, Gabriel; Rickelt, Steffen; Severe, Nicolas; Baryawno, Ninib; Faget, Julien; Savova, Virginia; Zemmour, David; Kline, Jaclyn; Siwicki, Marie; Garris, Christopher; Pucci, Ferdinando; Liao, Hsin-Wei; Lin, Yi-Jang; Newton, Andita; Yaghi, Omar K.; Iwamoto, Yoshiko; Tricot, Benoit; Wojtkiewicz, Gregory R.; Nahrendorf, Matthias; Cortez-Retamozo, Virna; Meylan, Etienne; Hynes, Richard O.; Demay, Marie; Klein, Allon; Bredella, Miriam A.; Scadden, David T.; Weissleder, Ralph; Pittet, Mikael J. (1 December 2017). \"Osteoblasts remotely supply lung tumors with cancer-promoting SiglecF neutrophils\". <i>Science</i>. <b>358</b> (6367): eaal5081. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.aal5081\">10.1126/science.aal5081</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Osteoblasts+remotely+supply+lung+tumors+with+cancer-promoting+SiglecF+neutrophils&amp;rft.volume=358&amp;rft.issue=6367&amp;rft.pages=eaal5081&amp;rft.date=2017-12-01&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.aal5081&amp;rft.aulast=Engblom&amp;rft.aufirst=Camilla&amp;rft.au=Pfirschke%2C+Christina&amp;rft.au=Zilionis%2C+Rapolas&amp;rft.au=Da+Silva+Martins%2C+Janaina&amp;rft.au=Bos%2C+Stijn+A.&amp;rft.au=Courties%2C+Gabriel&amp;rft.au=Rickelt%2C+Steffen&amp;rft.au=Severe%2C+Nicolas&amp;rft.au=Baryawno%2C+Ninib&amp;rft.au=Faget%2C+Julien&amp;rft.au=Savova%2C+Virginia&amp;rft.au=Zemmour%2C+David&amp;rft.au=Kline%2C+Jaclyn&amp;rft.au=Siwicki%2C+Marie&amp;rft.au=Garris%2C+Christopher&amp;rft.au=Pucci%2C+Ferdinando&amp;rft.au=Liao%2C+Hsin-Wei&amp;rft.au=Lin%2C+Yi-Jang&amp;rft.au=Newton%2C+Andita&amp;rft.au=Yaghi%2C+Omar+K.&amp;rft.au=Iwamoto%2C+Yoshiko&amp;rft.au=Tricot%2C+Benoit&amp;rft.au=Wojtkiewicz%2C+Gregory+R.&amp;rft.au=Nahrendorf%2C+Matthias&amp;rft.au=Cortez-Retamozo%2C+Virna&amp;rft.au=Meylan%2C+Etienne&amp;rft.au=Hynes%2C+Richard+O.&amp;rft.au=Demay%2C+Marie&amp;rft.au=Klein%2C+Allon&amp;rft.au=Bredella%2C+Miriam+A.&amp;rft.au=Scadden%2C+David+T.&amp;rft.au=Weissleder%2C+Ralph&amp;rft.au=Pittet%2C+Mikael+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-47\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-47\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Casbon, Amy-Jo; Reynaud, Damien; Park, Chanhyuk; Khuc, Emily; Gan, Dennis D.; Schepers, Koen; Passegu\u00e9, Emmanuelle; Werb, Zena (10 February 2015). \"Invasive breast cancer reprograms early myeloid differentiation in the bone marrow to generate immunosuppressive neutrophils\". <i>Proceedings of the National Academy of Sciences</i>. <b>112</b> (6): E566\u2013E575. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.1424927112\">10.1073/pnas.1424927112</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences&amp;rft.atitle=Invasive+breast+cancer+reprograms+early+myeloid+differentiation+in+the+bone+marrow+to+generate+immunosuppressive+neutrophils&amp;rft.volume=112&amp;rft.issue=6&amp;rft.pages=E566-E575&amp;rft.date=2015-02-10&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.1424927112&amp;rft.aulast=Casbon&amp;rft.aufirst=Amy-Jo&amp;rft.au=Reynaud%2C+Damien&amp;rft.au=Park%2C+Chanhyuk&amp;rft.au=Khuc%2C+Emily&amp;rft.au=Gan%2C+Dennis+D.&amp;rft.au=Schepers%2C+Koen&amp;rft.au=Passegu%C3%A9%2C+Emmanuelle&amp;rft.au=Werb%2C+Zena&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-48\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-48\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wculek, Stefanie K.; Malanchi, Ilaria (9 December 2015). \"Neutrophils support lung colonization of metastasis-initiating breast cancer cells\". <i>Nature</i>. <b>528</b> (7582): 413\u2013417. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nature16140\">10.1038/nature16140</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Neutrophils+support+lung+colonization+of+metastasis-initiating+breast+cancer+cells&amp;rft.volume=528&amp;rft.issue=7582&amp;rft.pages=413-417&amp;rft.date=2015-12-09&amp;rft_id=info%3Adoi%2F10.1038%2Fnature16140&amp;rft.aulast=Wculek&amp;rft.aufirst=Stefanie+K.&amp;rft.au=Malanchi%2C+Ilaria&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-49\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-49\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kowanetz, M.; Wu, X.; Lee, J.; Tan, M.; Hagenbeek, T.; Qu, X.; Yu, L.; Ross, J.; Korsisaari, N.; Cao, T.; Bou-Reslan, H.; Kallop, D.; Weimer, R.; Ludlam, M. J. C.; Kaminker, J. S.; Modrusan, Z.; van Bruggen, N.; Peale, F. V.; Carano, R.; Meng, Y. G.; Ferrara, N. (16 November 2010). \"Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes\". <i>Proceedings of the National Academy of Sciences</i>. <b>107</b> (50): 21248\u201321255. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.1015855107\">10.1073/pnas.1015855107</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences&amp;rft.atitle=Granulocyte-colony+stimulating+factor+promotes+lung+metastasis+through+mobilization+of+Ly6G%2BLy6C%2B+granulocytes&amp;rft.volume=107&amp;rft.issue=50&amp;rft.pages=21248-21255&amp;rft.date=2010-11-16&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.1015855107&amp;rft.aulast=Kowanetz&amp;rft.aufirst=M.&amp;rft.au=Wu%2C+X.&amp;rft.au=Lee%2C+J.&amp;rft.au=Tan%2C+M.&amp;rft.au=Hagenbeek%2C+T.&amp;rft.au=Qu%2C+X.&amp;rft.au=Yu%2C+L.&amp;rft.au=Ross%2C+J.&amp;rft.au=Korsisaari%2C+N.&amp;rft.au=Cao%2C+T.&amp;rft.au=Bou-Reslan%2C+H.&amp;rft.au=Kallop%2C+D.&amp;rft.au=Weimer%2C+R.&amp;rft.au=Ludlam%2C+M.+J.+C.&amp;rft.au=Kaminker%2C+J.+S.&amp;rft.au=Modrusan%2C+Z.&amp;rft.au=van+Bruggen%2C+N.&amp;rft.au=Peale%2C+F.+V.&amp;rft.au=Carano%2C+R.&amp;rft.au=Meng%2C+Y.+G.&amp;rft.au=Ferrara%2C+N.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-50\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-50\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Finisguerra, Veronica; Di Conza, Giusy; Di Matteo, Mario; Serneels, Jens; Costa, Sandra; Thompson, A. A. Roger; Wauters, Els; Walmsley, Sarah; Prenen, Hans; Granot, Zvi; Casazza, Andrea; Mazzone, Massimiliano (18 May 2015). \"MET is required for the recruitment of anti-tumoural neutrophils\". <i>Nature</i>. <b>522</b> (7556): 349\u2013353. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nature14407\">10.1038/nature14407</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=MET+is+required+for+the+recruitment+of+anti-tumoural+neutrophils&amp;rft.volume=522&amp;rft.issue=7556&amp;rft.pages=349-353&amp;rft.date=2015-05-18&amp;rft_id=info%3Adoi%2F10.1038%2Fnature14407&amp;rft.aulast=Finisguerra&amp;rft.aufirst=Veronica&amp;rft.au=Di+Conza%2C+Giusy&amp;rft.au=Di+Matteo%2C+Mario&amp;rft.au=Serneels%2C+Jens&amp;rft.au=Costa%2C+Sandra&amp;rft.au=Thompson%2C+A.+A.+Roger&amp;rft.au=Wauters%2C+Els&amp;rft.au=Walmsley%2C+Sarah&amp;rft.au=Prenen%2C+Hans&amp;rft.au=Granot%2C+Zvi&amp;rft.au=Casazza%2C+Andrea&amp;rft.au=Mazzone%2C+Massimiliano&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-51\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-51\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Granot, Zvi; Henke, Erik; Comen, Elizabeth A.; King, Tari A.; Norton, Larry; Benezra, Robert (September 2011). \"Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung\". <i>Cancer Cell</i>. <b>20</b> (3): 300\u2013314. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ccr.2011.08.012\">10.1016/j.ccr.2011.08.012</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Cell&amp;rft.atitle=Tumor+Entrained+Neutrophils+Inhibit+Seeding+in+the+Premetastatic+Lung&amp;rft.volume=20&amp;rft.issue=3&amp;rft.pages=300-314&amp;rft.date=2011-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccr.2011.08.012&amp;rft.aulast=Granot&amp;rft.aufirst=Zvi&amp;rft.au=Henke%2C+Erik&amp;rft.au=Comen%2C+Elizabeth+A.&amp;rft.au=King%2C+Tari+A.&amp;rft.au=Norton%2C+Larry&amp;rft.au=Benezra%2C+Robert&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-52\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-52\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fridlender, Zvi G.; Sun, Jing; Kim, Samuel; Kapoor, Veena; Cheng, Guanjun; Ling, Leona; Worthen, G. Scott; Albelda, Steven M. (September 2009). \"Polarization of Tumor-Associated Neutrophil Phenotype by TGF-\u03b2: \"N1\" versus \"N2\" TAN\". <i>Cancer Cell</i>. <b>16</b> (3): 183\u2013194. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.ccr.2009.06.017\">10.1016/j.ccr.2009.06.017</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Cell&amp;rft.atitle=Polarization+of+Tumor-Associated+Neutrophil+Phenotype+by+TGF-%CE%B2%3A+%22N1%22+versus+%22N2%22+TAN&amp;rft.volume=16&amp;rft.issue=3&amp;rft.pages=183-194&amp;rft.date=2009-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ccr.2009.06.017&amp;rft.aulast=Fridlender&amp;rft.aufirst=Zvi+G.&amp;rft.au=Sun%2C+Jing&amp;rft.au=Kim%2C+Samuel&amp;rft.au=Kapoor%2C+Veena&amp;rft.au=Cheng%2C+Guanjun&amp;rft.au=Ling%2C+Leona&amp;rft.au=Worthen%2C+G.+Scott&amp;rft.au=Albelda%2C+Steven+M.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-53\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-53\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Engblom, Camilla; Pfirschke, Christina; Zilionis, Rapolas; Da Silva Martins, Janaina; Bos, Stijn A.; Courties, Gabriel; Rickelt, Steffen; Severe, Nicolas; Baryawno, Ninib; Faget, Julien; Savova, Virginia; Zemmour, David; Kline, Jaclyn; Siwicki, Marie; Garris, Christopher; Pucci, Ferdinando; Liao, Hsin-Wei; Lin, Yi-Jang; Newton, Andita; Yaghi, Omar K.; Iwamoto, Yoshiko; Tricot, Benoit; Wojtkiewicz, Gregory R.; Nahrendorf, Matthias; Cortez-Retamozo, Virna; Meylan, Etienne; Hynes, Richard O.; Demay, Marie; Klein, Allon; Bredella, Miriam A.; Scadden, David T.; Weissleder, Ralph; Pittet, Mikael J. (1 December 2017). \"Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils\". <i>Science</i>. <b>358</b> (6367): eaal5081. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.aal5081\">10.1126/science.aal5081</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Osteoblasts+remotely+supply+lung+tumors+with+cancer-promoting+SiglecFhigh+neutrophils&amp;rft.volume=358&amp;rft.issue=6367&amp;rft.pages=eaal5081&amp;rft.date=2017-12-01&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.aal5081&amp;rft.aulast=Engblom&amp;rft.aufirst=Camilla&amp;rft.au=Pfirschke%2C+Christina&amp;rft.au=Zilionis%2C+Rapolas&amp;rft.au=Da+Silva+Martins%2C+Janaina&amp;rft.au=Bos%2C+Stijn+A.&amp;rft.au=Courties%2C+Gabriel&amp;rft.au=Rickelt%2C+Steffen&amp;rft.au=Severe%2C+Nicolas&amp;rft.au=Baryawno%2C+Ninib&amp;rft.au=Faget%2C+Julien&amp;rft.au=Savova%2C+Virginia&amp;rft.au=Zemmour%2C+David&amp;rft.au=Kline%2C+Jaclyn&amp;rft.au=Siwicki%2C+Marie&amp;rft.au=Garris%2C+Christopher&amp;rft.au=Pucci%2C+Ferdinando&amp;rft.au=Liao%2C+Hsin-Wei&amp;rft.au=Lin%2C+Yi-Jang&amp;rft.au=Newton%2C+Andita&amp;rft.au=Yaghi%2C+Omar+K.&amp;rft.au=Iwamoto%2C+Yoshiko&amp;rft.au=Tricot%2C+Benoit&amp;rft.au=Wojtkiewicz%2C+Gregory+R.&amp;rft.au=Nahrendorf%2C+Matthias&amp;rft.au=Cortez-Retamozo%2C+Virna&amp;rft.au=Meylan%2C+Etienne&amp;rft.au=Hynes%2C+Richard+O.&amp;rft.au=Demay%2C+Marie&amp;rft.au=Klein%2C+Allon&amp;rft.au=Bredella%2C+Miriam+A.&amp;rft.au=Scadden%2C+David+T.&amp;rft.au=Weissleder%2C+Ralph&amp;rft.au=Pittet%2C+Mikael+J.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-54\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-54\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Coffelt, Seth B.; Wellenstein, Max D.; de Visser, Karin E. (10 June 2016). \"Neutrophils in cancer: neutral no more\". <i>Nature Reviews Cancer</i>. <b>16</b> (7): 431\u2013446. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrc.2016.52\">10.1038/nrc.2016.52</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Cancer&amp;rft.atitle=Neutrophils+in+cancer%3A+neutral+no+more&amp;rft.volume=16&amp;rft.issue=7&amp;rft.pages=431-446&amp;rft.date=2016-06-10&amp;rft_id=info%3Adoi%2F10.1038%2Fnrc.2016.52&amp;rft.aulast=Coffelt&amp;rft.aufirst=Seth+B.&amp;rft.au=Wellenstein%2C+Max+D.&amp;rft.au=de+Visser%2C+Karin+E.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-55\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-55\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gabrilovich, Dmitry I. (3 January 2017). \"Myeloid-Derived Suppressor Cells\". <i>Cancer Immunology Research</i>. <b>5</b> (1): 3\u20138. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1158/2326-6066.CIR-16-0297\">10.1158/2326-6066.CIR-16-0297</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Immunology+Research&amp;rft.atitle=Myeloid-Derived+Suppressor+Cells&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=3-8&amp;rft.date=2017-01-03&amp;rft_id=info%3Adoi%2F10.1158%2F2326-6066.CIR-16-0297&amp;rft.aulast=Gabrilovich&amp;rft.aufirst=Dmitry+I.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-56\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-56\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Turcotte, Simon; Rosenberg, Steven A. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3578602\">\"Immunotherapy of Metastatic Solid Cancers\"</a>. <i>Advances in Surgery</i>. <b>45</b>: 342\u2013360. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.yasu.2011.04.003\">10.1016/j.yasu.2011.04.003</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3578602\">3578602</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21954698\">21954698</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advances+in+Surgery&amp;rft.atitle=Immunotherapy+of+Metastatic+Solid+Cancers&amp;rft.volume=45&amp;rft.pages=342-360&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3578602&amp;rft_id=info%3Apmid%2F21954698&amp;rft_id=info%3Adoi%2F10.1016%2Fj.yasu.2011.04.003&amp;rft.aulast=Turcotte&amp;rft.aufirst=Simon&amp;rft.au=Rosenberg%2C+Steven+A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3578602&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-57\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-57\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Clayton, Aled; Tabi, Zsuzsanna (May\u2013June 2005). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.bcmd.2005.03.003\">\"Exosomes and the MICA-NKG2D system in cancer\"</a>. <i>Blood Cells, Molecules, and Diseases</i>. <b>34</b> (3): 206\u2013213. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.bcmd.2005.03.003\">10.1016/j.bcmd.2005.03.003</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Blood+Cells%2C+Molecules%2C+and+Diseases&amp;rft.atitle=Exosomes+and+the+MICA-NKG2D+system+in+cancer&amp;rft.volume=34&amp;rft.issue=3&amp;rft.pages=206-213&amp;rft.date=2005-05%2F2005-06&amp;rft_id=info%3Adoi%2F10.1016%2Fj.bcmd.2005.03.003&amp;rft.aulast=Clayton&amp;rft.aufirst=Aled&amp;rft.au=Tabi%2C+Zsuzsanna&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.bcmd.2005.03.003&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Tisty-58\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Tisty_58-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Tisty_58-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Tisty_58-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Tisty, Thea D.; Coussens, Lisa M. (February 2006). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1146/annurev.pathol.1.110304.100224\">\"Tumor stroma and regulation of cancer development\"</a>. <i>Annual Review of Pathology: Mechanisms of Disease</i>. <b>1</b>: 11\u2013150. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1146/annurev.pathol.1.110304.100224\">10.1146/annurev.pathol.1.110304.100224</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annual+Review+of+Pathology%3A+Mechanisms+of+Disease&amp;rft.atitle=Tumor+stroma+and+regulation+of+cancer+development&amp;rft.volume=1&amp;rft.pages=11-150&amp;rft.date=2006-02&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev.pathol.1.110304.100224&amp;rft.aulast=Tisty&amp;rft.aufirst=Thea+D.&amp;rft.au=Coussens%2C+Lisa+M.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1146%2Fannurev.pathol.1.110304.100224&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-59\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-59\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Gaggioli, Cedric; Hooper, Steven; Hidalgo-Carcedo, Cristina; Grosse, Robert; Marshall, John F.; Harrington, Kevin; Sahai, Erik (25 November 2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1038/ncb1658\">\"Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells\"</a>. <i>Nature Cell Biology</i>. <b>9</b>: 1392\u20131400. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/ncb1658\">10.1038/ncb1658</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18037882\">18037882</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Cell+Biology&amp;rft.atitle=Fibroblast-led+collective+invasion+of+carcinoma+cells+with+differing+roles+for+RhoGTPases+in+leading+and+following+cells&amp;rft.volume=9&amp;rft.pages=1392-1400&amp;rft.date=2007-11-25&amp;rft_id=info%3Adoi%2F10.1038%2Fncb1658&amp;rft_id=info%3Apmid%2F18037882&amp;rft.aulast=Gaggioli&amp;rft.aufirst=Cedric&amp;rft.au=Hooper%2C+Steven&amp;rft.au=Hidalgo-Carcedo%2C+Cristina&amp;rft.au=Grosse%2C+Robert&amp;rft.au=Marshall%2C+John+F.&amp;rft.au=Harrington%2C+Kevin&amp;rft.au=Sahai%2C+Erik&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1038%2Fncb1658&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Pupa-60\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Pupa_60-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Pupa_60-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pupa, Serenella M.; M\u00e9nard, Sylvie; Forti, Stefania; Tagliabue, Elda (September 2002). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1002/jcp.10142\">\"New insights into the role of extracellular matrix during tumor onset and progression\"</a>. <i>Journal of Cellular Physiology</i>. <b>192</b> (3): 259\u2013267. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1002/jcp.10142\">10.1002/jcp.10142</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Cellular+Physiology&amp;rft.atitle=New+insights+into+the+role+of+extracellular+matrix+during+tumor+onset+and+progression&amp;rft.volume=192&amp;rft.issue=3&amp;rft.pages=259-267&amp;rft.date=2002-09&amp;rft_id=info%3Adoi%2F10.1002%2Fjcp.10142&amp;rft.aulast=Pupa&amp;rft.aufirst=Serenella+M.&amp;rft.au=M%C3%A9nard%2C+Sylvie&amp;rft.au=Forti%2C+Stefania&amp;rft.au=Tagliabue%2C+Elda&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1002%2Fjcp.10142&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-61\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-61\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Montgomery, Anthony M.P.; Reisfeld, Ralph A.; Cheresh, David A. (13 September 1994). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC44705\">\"Integrin \u03b1v\u03b23 rescues melanoma cells from apoptosis in three-dimensional dermal collagen\"</a>. <i>Proceedings of the National Academy of Sciences of the United States of America</i>. <b>91</b> (19): 8856\u20138860. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1073/pnas.91.19.8856\">10.1073/pnas.91.19.8856</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC44705\">44705</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7522323\">7522323</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+of+the+United+States+of+America&amp;rft.atitle=Integrin+%CE%B1v%CE%B23+rescues+melanoma+cells+from+apoptosis+in+three-dimensional+dermal+collagen&amp;rft.volume=91&amp;rft.issue=19&amp;rft.pages=8856-8860&amp;rft.date=1994-09-13&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC44705&amp;rft_id=info%3Apmid%2F7522323&amp;rft_id=info%3Adoi%2F10.1073%2Fpnas.91.19.8856&amp;rft.aulast=Montgomery&amp;rft.aufirst=Anthony+M.P.&amp;rft.au=Reisfeld%2C+Ralph+A.&amp;rft.au=Cheresh%2C+David+A.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC44705&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-62\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-62\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bergers, Gabriele; Coussens, Lisa M (1 February 2000). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/S0959-437X(99)00043-X\">\"Extrinsic regulators of epithelial tumor progression: metalloproteinases\"</a>. <i>Current Opinion in Genetics &amp; Development</i>. <b>10</b> (1): 120\u2013127. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0959-437X%2899%2900043-X\">10.1016/S0959-437X(99)00043-X</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Opinion+in+Genetics+%26+Development&amp;rft.atitle=Extrinsic+regulators+of+epithelial+tumor+progression%3A+metalloproteinases&amp;rft.volume=10&amp;rft.issue=1&amp;rft.pages=120-127&amp;rft.date=2000-02-01&amp;rft_id=info%3Adoi%2F10.1016%2FS0959-437X%2899%2900043-X&amp;rft.aulast=Bergers&amp;rft.aufirst=Gabriele&amp;rft.au=Coussens%2C+Lisa+M&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2FS0959-437X%2899%2900043-X&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-63\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-63\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Sinkus, R.; Lorenzen, J.; Schrader, D.; Lorenzen, M.; Dargatz, M.; Holz, D. (2000). <a rel=\"nofollow\" class=\"external text\" href=\"http://iopscience.iop.org/0031-9155/45/6/317/pdf/m00617.pdf\">\"High-resolution tensor MR elastography for breast tumour detection\"</a> <span style=\"font-size:85%;\">(PDF)</span>. <i>Physics in Medicine and Biology</i>. <b>45</b>: 1649\u20131664. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1088/0031-9155/45/6/317\">10.1088/0031-9155/45/6/317</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Physics+in+Medicine+and+Biology&amp;rft.atitle=High-resolution+tensor+MR+elastography+for+breast+tumour+detection&amp;rft.volume=45&amp;rft.pages=1649-1664&amp;rft.date=2000&amp;rft_id=info%3Adoi%2F10.1088%2F0031-9155%2F45%2F6%2F317&amp;rft.aulast=Sinkus&amp;rft.aufirst=R.&amp;rft.au=Lorenzen%2C+J.&amp;rft.au=Schrader%2C+D.&amp;rft.au=Lorenzen%2C+M.&amp;rft.au=Dargatz%2C+M.&amp;rft.au=Holz%2C+D.&amp;rft_id=http%3A%2F%2Fiopscience.iop.org%2F0031-9155%2F45%2F6%2F317%2Fpdf%2Fm00617.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Levental-64\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Levental_64-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Levental, Kandice R.; Yu, Hongmei; Kass, Laura; Lakins, Johnathon N.; Egeblad, Mikala; Erler, Janine T.; Fong, Sheri F.T.; Csiszar, Katalin; Giaccia, Amato; Weninger, Wolfgang; Yamauchi, Mitsuo; Gasser, David L.; Weaver, Valerie M. (25 November 2009). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/j.cell.2009.10.027\">\"Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling\"</a>. <i>Cell</i>. <b>139</b> (5): 891\u2013906. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.cell.2009.10.027\">10.1016/j.cell.2009.10.027</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2788004\">2788004</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19931152\">19931152</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cell&amp;rft.atitle=Matrix+Crosslinking+Forces+Tumor+Progression+by+Enhancing+Integrin+Signaling&amp;rft.volume=139&amp;rft.issue=5&amp;rft.pages=891-906&amp;rft.date=2009-11-25&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2788004&amp;rft_id=info%3Apmid%2F19931152&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cell.2009.10.027&amp;rft.aulast=Levental&amp;rft.aufirst=Kandice+R.&amp;rft.au=Yu%2C+Hongmei&amp;rft.au=Kass%2C+Laura&amp;rft.au=Lakins%2C+Johnathon+N.&amp;rft.au=Egeblad%2C+Mikala&amp;rft.au=Erler%2C+Janine+T.&amp;rft.au=Fong%2C+Sheri+F.T.&amp;rft.au=Csiszar%2C+Katalin&amp;rft.au=Giaccia%2C+Amato&amp;rft.au=Weninger%2C+Wolfgang&amp;rft.au=Yamauchi%2C+Mitsuo&amp;rft.au=Gasser%2C+David+L.&amp;rft.au=Weaver%2C+Valerie+M.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2Fj.cell.2009.10.027&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-pmid21749361-65\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-pmid21749361_65-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-pmid21749361_65-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Mraz, M.; Zent, C. S.; Church, A. K.; Jelinek, D. F.; Wu, X.; Pospisilova, S.; Ansell, S. M.; Novak, A. J.; Kay, N. E.; Witzig, T. E.; Nowakowski, G. S. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4405035\">\"Bone marrow stromal cells protect lymphoma B-cells from rituximab-induced apoptosis and targeting integrin \u03b1-4-\u03b2-1 (VLA-4) with natalizumab can overcome this resistance\"</a>. <i>British Journal of Haematology</i>. <b>155</b> (1): 53\u201364. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1365-2141.2011.08794.x\">10.1111/j.1365-2141.2011.08794.x</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4405035\">4405035</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21749361\">21749361</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Haematology&amp;rft.atitle=Bone+marrow+stromal+cells+protect+lymphoma+B-cells+from+rituximab-induced+apoptosis+and+targeting+integrin+%CE%B1-4-%CE%B2-1+%28VLA-4%29+with+natalizumab+can+overcome+this+resistance&amp;rft.volume=155&amp;rft.issue=1&amp;rft.pages=53-64&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4405035&amp;rft_id=info%3Apmid%2F21749361&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1365-2141.2011.08794.x&amp;rft.aulast=Mraz&amp;rft.aufirst=M.&amp;rft.au=Zent%2C+C.+S.&amp;rft.au=Church%2C+A.+K.&amp;rft.au=Jelinek%2C+D.+F.&amp;rft.au=Wu%2C+X.&amp;rft.au=Pospisilova%2C+S.&amp;rft.au=Ansell%2C+S.+M.&amp;rft.au=Novak%2C+A.+J.&amp;rft.au=Kay%2C+N.+E.&amp;rft.au=Witzig%2C+T.+E.&amp;rft.au=Nowakowski%2C+G.+S.&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4405035&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-66\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-66\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Unezaki, Sakae; Maruyama, Kazuo; Hosoda, Jun-Ichi; Nagae, Itsuro; Koyanagi, Yasuhisa; Nakata, Mikiho; Ishida, Osamu; Iwatsuru, Motoharu; Tsuchiya, Seishi (22 November 1996). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1016/S0378-5173(96)04674-1\">\"Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy\"</a>. <i>International Journal of Pharmaceutics</i>. <b>144</b> (1): 11\u201317. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0378-5173%2896%2904674-1\">10.1016/S0378-5173(96)04674-1</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Pharmaceutics&amp;rft.atitle=Direct+measurement+of+the+extravasation+of+polyethyleneglycol-coated+liposomes+into+solid+tumor+tissue+by+in+vivo+fluorescence+microscopy&amp;rft.volume=144&amp;rft.issue=1&amp;rft.pages=11-17&amp;rft.date=1996-11-22&amp;rft_id=info%3Adoi%2F10.1016%2FS0378-5173%2896%2904674-1&amp;rft.aulast=Unezaki&amp;rft.aufirst=Sakae&amp;rft.au=Maruyama%2C+Kazuo&amp;rft.au=Hosoda%2C+Jun-Ichi&amp;rft.au=Nagae%2C+Itsuro&amp;rft.au=Koyanagi%2C+Yasuhisa&amp;rft.au=Nakata%2C+Mikiho&amp;rft.au=Ishida%2C+Osamu&amp;rft.au=Iwatsuru%2C+Motoharu&amp;rft.au=Tsuchiya%2C+Seishi&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1016%2FS0378-5173%2896%2904674-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-67\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-67\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Lilavivat, Seth; Sardar, Debosmita; Jana, Subrata; Thomas, Geoffrey C.; Woycechowsky, Kenneth J. (15 August 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1021/ja302743g\">\"In vivo encapsulation of nucleic acids using an engineered nonviral protein capsid\"</a>. <i>Journal of the American Chemical Society</i>. <b>134</b> (32): 13152\u201313155. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1021/ja302743g\">10.1021/ja302743g</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/22827162\">22827162</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Chemical+Society&amp;rft.atitle=In+vivo+encapsulation+of+nucleic+acids+using+an+engineered+nonviral+protein+capsid&amp;rft.volume=134&amp;rft.issue=32&amp;rft.pages=13152-13155&amp;rft.date=2012-08-15&amp;rft_id=info%3Adoi%2F10.1021%2Fja302743g&amp;rft_id=info%3Apmid%2F22827162&amp;rft.aulast=Lilavivat&amp;rft.aufirst=Seth&amp;rft.au=Sardar%2C+Debosmita&amp;rft.au=Jana%2C+Subrata&amp;rft.au=Thomas%2C+Geoffrey+C.&amp;rft.au=Woycechowsky%2C+Kenneth+J.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1021%2Fja302743g&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-68\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-68\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ramishetti, Srinivas; Huang, Leaf (December 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/doi:10.4155/tde.12.127\">\"Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy\"</a>. <i>Therapeutic Delivery</i>. <b>3</b> (12): 1429\u20131445. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.4155/tde.12.127\">10.4155/tde.12.127</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3584330\">3584330</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Therapeutic+Delivery&amp;rft.atitle=Intelligent+design+of+multifunctional+lipid-coated+nanoparticle+platforms+for+cancer+therapy&amp;rft.volume=3&amp;rft.issue=12&amp;rft.pages=1429-1445&amp;rft.date=2012-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3584330&amp;rft_id=info%3Adoi%2F10.4155%2Ftde.12.127&amp;rft.aulast=Ramishetti&amp;rft.aufirst=Srinivas&amp;rft.au=Huang%2C+Leaf&amp;rft_id=https%3A%2F%2Fdx.doi.org%2Fdoi%3A10.4155%2Ftde.12.127&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-69\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-69\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jain, Rakesh K. (1987). \"Transport of molecules in the tumor interstitium: a review\". <i>Cancer Research</i>. <b>47</b>: 3039\u20133051.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cancer+Research&amp;rft.atitle=Transport+of+molecules+in+the+tumor+interstitium%3A+a+review&amp;rft.volume=47&amp;rft.pages=3039-3051&amp;rft.date=1987&amp;rft.aulast=Jain&amp;rft.aufirst=Rakesh+K.&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-70\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-70\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Maor, Yehoshua; Yu, Jinlong; Kuzontkoski, Paula M.; Dezube, Bruce J.; Zhang, Xuefeng; Groopman, Jerome E. (July 2012). <a rel=\"nofollow\" class=\"external text\" href=\"https://dx.doi.org/10.1177/1947601912466556\">\"Cannabidiol Inhibits Growth and Induces Programmed Cell Death in Kaposi Sarcoma\u2013Associated Herpesvirus-Infected Endothelium\"</a>. <i>Genes Cancer</i>. <b>7\u20138</b>: 512\u2013520. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1177/1947601912466556\">10.1177/1947601912466556</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3527984\">3527984</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genes+Cancer&amp;rft.atitle=Cannabidiol+Inhibits+Growth+and+Induces+Programmed+Cell+Death+in+Kaposi+Sarcoma%E2%80%93Associated+Herpesvirus-Infected+Endothelium&amp;rft.volume=7%E2%80%938&amp;rft.pages=512-520&amp;rft.date=2012-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3527984&amp;rft_id=info%3Adoi%2F10.1177%2F1947601912466556&amp;rft.aulast=Maor&amp;rft.aufirst=Yehoshua&amp;rft.au=Yu%2C+Jinlong&amp;rft.au=Kuzontkoski%2C+Paula+M.&amp;rft.au=Dezube%2C+Bruce+J.&amp;rft.au=Zhang%2C+Xuefeng&amp;rft.au=Groopman%2C+Jerome+E.&amp;rft_id=https%3A%2F%2Fdx.doi.org%2F10.1177%2F1947601912466556&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ATumor+microenvironment\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n\n<!-- \nNewPP limit report\nParsed by mw2233\nCached time: 20180912191348\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.708 seconds\nReal time usage: 0.733 seconds\nPreprocessor visited node count: 4688/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 166128/2097152 bytes\nTemplate argument size: 118/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 120316/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.387/10.000 seconds\nLua memory usage: 3.22 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  542.058      1 Template:Reflist\n100.00%  542.058      1 -total\n 71.25%  386.243     66 Template:Cite_journal\n  8.54%   46.269      2 Template:Cite_web\n  0.47%    2.544      1 Template:Main_other\n  0.38%    2.046      1 Template:Column-width\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:38925137-0!canonical and timestamp 20180912191348 and revision id 855917314\n -->\n</div>"},"langlinks":[{"lang":"it","url":"https://it.wikipedia.org/wiki/Microambiente_del_tumore","langname":"Italian","autonym":"italiano","*":"Microambiente del tumore"},{"lang":"zh","url":"https://zh.wikipedia.org/wiki/%E8%82%BF%E7%98%A4%E5%BE%AE%E7%8E%AF%E5%A2%83","langname":"Chinese","autonym":"\u4e2d\u6587","*":"\u80bf\u7624\u5fae\u73af\u5883"}],"categories":[{"sortkey":"","hidden":"","*":"CS1_errors:_dates"},{"sortkey":"","*":"Tumor"}],"links":[{"ns":0,"exists":"","*":"ACTA2"},{"ns":0,"exists":"","*":"Adenocarcinoma"},{"ns":0,"exists":"","*":"Adhesion"},{"ns":0,"exists":"","*":"Adoptive cell transfer"},{"ns":0,"exists":"","*":"Albumin"},{"ns":0,"exists":"","*":"Alpha-v beta-3"},{"ns":0,"exists":"","*":"Angiogenesis"},{"ns":0,"exists":"","*":"Antigens"},{"ns":0,"exists":"","*":"Apoptosis"},{"ns":0,"exists":"","*":"Axitinib"},{"ns":0,"exists":"","*":"Basal lamina"},{"ns":0,"exists":"","*":"Basement membrane"},{"ns":0,"exists":"","*":"Basic fibroblast growth factor"},{"ns":0,"exists":"","*":"Bevacizumab"},{"ns":0,"exists":"","*":"CCL2"},{"ns":0,"exists":"","*":"CCL5"},{"ns":0,"exists":"","*":"CCR2"},{"ns":0,"exists":"","*":"CD103"},{"ns":0,"exists":"","*":"CD276"},{"ns":0,"exists":"","*":"CD47"},{"ns":0,"exists":"","*":"CD8+"},{"ns":0,"exists":"","*":"CTLA-4"},{"ns":0,"exists":"","*":"CXCL12"},{"ns":0,"exists":"","*":"CXCR4"},{"ns":0,"exists":"","*":"Cancer-associated fibroblasts"},{"ns":0,"exists":"","*":"Cancer/testis antigens"},{"ns":0,"exists":"","*":"Cannabidiol"},{"ns":0,"exists":"","*":"Cannabis"},{"ns":0,"exists":"","*":"Capsids"},{"ns":0,"exists":"","*":"Carcinoma"},{"ns":0,"exists":"","*":"Catabolism"},{"ns":0,"exists":"","*":"Chemokine"},{"ns":0,"exists":"","*":"Chemokines"},{"ns":0,"exists":"","*":"Chimeric antigen receptor"},{"ns":0,"exists":"","*":"Collagenase"},{"ns":0,"exists":"","*":"Collagens"},{"ns":0,"exists":"","*":"Colony-stimulating factor-1 receptor"},{"ns":0,"exists":"","*":"Colorectal cancer"},{"ns":0,"exists":"","*":"DNA mismatch repair"},{"ns":0,"exists":"","*":"DNA repair"},{"ns":0,"exists":"","*":"Daunorubicin"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Doxorubicin"},{"ns":0,"exists":"","*":"Elastin"},{"ns":0,"exists":"","*":"Endostatin"},{"ns":0,"exists":"","*":"Endothelin"},{"ns":0,"exists":"","*":"Enhanced permeability and retention effect"},{"ns":0,"exists":"","*":"Eos (protein)"},{"ns":0,"exists":"","*":"Epidermal growth factor"},{"ns":0,"exists":"","*":"Epidermal growth factor receptor"},{"ns":0,"exists":"","*":"Epithelial-mesenchymal transition"},{"ns":0,"exists":"","*":"Exosome (vesicle)"},{"ns":0,"exists":"","*":"Extracellular matrix"},{"ns":0,"exists":"","*":"FOXP3"},{"ns":0,"exists":"","*":"Fas ligand"},{"ns":0,"exists":"","*":"Fibroblast"},{"ns":0,"exists":"","*":"Fibroblast activation protein, alpha"},{"ns":0,"exists":"","*":"Fibroblast growth factor"},{"ns":0,"exists":"","*":"Fibroblasts"},{"ns":0,"exists":"","*":"Fibrocyte"},{"ns":0,"exists":"","*":"Fibronectin"},{"ns":0,"exists":"","*":"Gemcitabine"},{"ns":0,"exists":"","*":"Genome instability"},{"ns":0,"exists":"","*":"Glioma"},{"ns":0,"exists":"","*":"Glycoproteins"},{"ns":0,"exists":"","*":"Glycosaminoglycans"},{"ns":0,"exists":"","*":"Granulocyte macrophage colony-stimulating factor"},{"ns":0,"exists":"","*":"HIF1A"},{"ns":0,"exists":"","*":"Hematopoietic stem cell"},{"ns":0,"exists":"","*":"Heparin-binding EGF-like growth factor"},{"ns":0,"exists":"","*":"Hypoxia-inducible factors"},{"ns":0,"exists":"","*":"Imatinib"},{"ns":0,"exists":"","*":"Immune checkpoint inhibitor"},{"ns":0,"exists":"","*":"Immune response"},{"ns":0,"exists":"","*":"Immune system"},{"ns":0,"exists":"","*":"Immune tolerance"},{"ns":0,"exists":"","*":"Immunoediting"},{"ns":0,"exists":"","*":"Indole 2,3-dioxygenase"},{"ns":0,"exists":"","*":"Inflammation"},{"ns":0,"exists":"","*":"Innate immune system"},{"ns":0,"exists":"","*":"Insulin-like growth factor"},{"ns":0,"exists":"","*":"Integrins"},{"ns":0,"exists":"","*":"Intercellular adhesion molecule-1"},{"ns":0,"exists":"","*":"Interferon-\u03b3"},{"ns":0,"exists":"","*":"Interleukin-10 receptor"},{"ns":0,"exists":"","*":"Interleukin 10"},{"ns":0,"exists":"","*":"Interleukin 12"},{"ns":0,"exists":"","*":"Interleukin 13"},{"ns":0,"exists":"","*":"Interleukin 4"},{"ns":0,"exists":"","*":"Interleukin 6"},{"ns":0,"exists":"","*":"Interstitial fluid"},{"ns":0,"exists":"","*":"Intravasate"},{"ns":0,"exists":"","*":"Kaposi's sarcoma"},{"ns":0,"exists":"","*":"Kynurenine"},{"ns":0,"exists":"","*":"Lactic acid"},{"ns":0,"exists":"","*":"Leukemias"},{"ns":0,"exists":"","*":"Liposomes"},{"ns":0,"exists":"","*":"Lymph node"},{"ns":0,"exists":"","*":"Lymphomas"},{"ns":0,"exists":"","*":"Lysyl oxidase"},{"ns":0,"exists":"","*":"Macrophage"},{"ns":0,"exists":"","*":"Macrophage colony-stimulating factor"},{"ns":0,"exists":"","*":"Macrophages"},{"ns":0,"exists":"","*":"Matrix metalloproteinase"},{"ns":0,"exists":"","*":"Melanoma"},{"ns":0,"exists":"","*":"Mercury (element)"},{"ns":0,"exists":"","*":"Mesenchymal stem cells"},{"ns":0,"exists":"","*":"Methylcholanthrene"},{"ns":0,"exists":"","*":"MicroRNA"},{"ns":0,"exists":"","*":"Monoclonal antibody"},{"ns":0,"exists":"","*":"Myeloid"},{"ns":0,"exists":"","*":"Myelomonocytic"},{"ns":0,"exists":"","*":"Myocardial infarction"},{"ns":0,"exists":"","*":"Myocardium"},{"ns":0,"exists":"","*":"NF-\u03baB"},{"ns":0,"exists":"","*":"Natalizumab"},{"ns":0,"exists":"","*":"Natural killer T cell"},{"ns":0,"exists":"","*":"Natural killer cell"},{"ns":0,"exists":"","*":"Neutrophils"},{"ns":0,"exists":"","*":"Nitric oxide synthase"},{"ns":0,"exists":"","*":"Non-small-cell lung carcinoma"},{"ns":0,"exists":"","*":"Nucleotide excision repair"},{"ns":0,"exists":"","*":"Oncoprotein"},{"ns":0,"exists":"","*":"PDGFRA"},{"ns":0,"exists":"","*":"PDGFRB"},{"ns":0,"exists":"","*":"Paclitaxel"},{"ns":0,"exists":"","*":"Paracrine"},{"ns":0,"exists":"","*":"Partial pressure"},{"ns":0,"exists":"","*":"Pazopanib"},{"ns":0,"exists":"","*":"Pericyte"},{"ns":0,"exists":"","*":"Pericytes"},{"ns":0,"exists":"","*":"Perlecan"},{"ns":0,"exists":"","*":"Phagocytosis"},{"ns":0,"exists":"","*":"Platelet-derived growth factor"},{"ns":0,"exists":"","*":"Platelet derived growth factor receptor"},{"ns":0,"exists":"","*":"Protein-bound paclitaxel"},{"ns":0,"exists":"","*":"Proteoglycans"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"RGS5"},{"ns":0,"exists":"","*":"Receptor tyrosine kinase"},{"ns":0,"exists":"","*":"Regulatory T cells"},{"ns":0,"exists":"","*":"Reverse Warburg Effect"},{"ns":0,"exists":"","*":"Sarcomas"},{"ns":0,"exists":"","*":"Signal-regulatory protein alpha"},{"ns":0,"exists":"","*":"Sorafenib"},{"ns":0,"exists":"","*":"Stephen Paget"},{"ns":0,"exists":"","*":"Stroma (animal tissue)"},{"ns":0,"exists":"","*":"Stromal cell"},{"ns":0,"exists":"","*":"Sunitinib"},{"ns":0,"exists":"","*":"TNF-related apoptosis-inducing ligand"},{"ns":0,"exists":"","*":"T cell"},{"ns":0,"exists":"","*":"Trabectedin"},{"ns":0,"exists":"","*":"Transforming growth factor beta"},{"ns":0,"exists":"","*":"Tryptophan"},{"ns":0,"exists":"","*":"Tumor-associated endothelial cells"},{"ns":0,"exists":"","*":"Tumor-infiltrating lymphocytes"},{"ns":0,"exists":"","*":"Tumor hypoxia"},{"ns":0,"exists":"","*":"Tumor infiltrating lymphocyte"},{"ns":0,"exists":"","*":"Tumor necrosis factor"},{"ns":0,"exists":"","*":"Tumor necrosis factor-\u03b1"},{"ns":0,"exists":"","*":"Tumour heterogeneity"},{"ns":0,"exists":"","*":"Tumstatin"},{"ns":0,"exists":"","*":"VEGF receptors"},{"ns":0,"exists":"","*":"Vascular endothelial growth factor"},{"ns":0,"exists":"","*":"Vimentin"},{"ns":0,"exists":"","*":"Vincristine"},{"ns":0,"exists":"","*":"Vitamin D"},{"ns":0,"exists":"","*":"Warburg effect"},{"ns":0,"exists":"","*":"Wound healing"},{"ns":0,"exists":"","*":"Xenografts"},{"ns":12,"exists":"","*":"Help:CS1 errors"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite web"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["http://www.cancer.gov/dictionary?cdrid=561725","http://www.sciencemag.org/content/348/6230/74.full","//doi.org/10.1126/science.aaa6204","http://www.sciencedirect.com/science/article/pii/S0958166916300301","//doi.org/10.1016/j.copbio.2016.02.007","http://www.sciencedirect.com/science/article/pii/S1043466616300229","//doi.org/10.1016/j.cyto.2016.01.021","//www.ncbi.nlm.nih.gov/pubmed/26854213","http://cancerres.aacrjournals.org/content/49/9/2383.full.pdf","https://dx.doi.org/10.1016/j.canlet.2005.12.005","//doi.org/10.1016/j.canlet.2005.12.005","//www.ncbi.nlm.nih.gov/pubmed/16413116","http://cancer.stanford.edu/information/cancerOverview.html","//www.ncbi.nlm.nih.gov/pubmed/8899072","//doi.org/10.1016/0304-4165(84)90258-7","//www.ncbi.nlm.nih.gov/pubmed/6365177","https://dx.doi.org/10.1016/j.jconrel.2010.08.027","//doi.org/10.1016/j.jconrel.2010.08.027","https://dx.doi.org/10.1016/j.suronc.2011.09.001","//doi.org/10.1016/j.suronc.2011.09.001","https://dx.doi.org/10.1016/S1535-6108(03)00336-2","//doi.org/10.1016/S1535-6108(03)00336-2","//doi.org/10.1016/j.mrfmmm.2004.03.013","//www.ncbi.nlm.nih.gov/pubmed/15603753","https://dx.doi.org/10.1038/nrc1478","//doi.org/10.1038/nrc1478","//www.ncbi.nlm.nih.gov/pubmed/15516961","https://dx.doi.org/10.1002/(SICI)1522-2594(199904)41:4","//doi.org/10.1002/(SICI)1522-2594(199904)41:4%3C743::AID-MRM13%3E3.0.CO;2-Z","https://dx.doi.org/10.1158/0008-5472.CAN-12-2796","//doi.org/10.1158/0008-5472.CAN-12-2796","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3594450","//www.ncbi.nlm.nih.gov/pubmed/23288510","//doi.org/10.1056/NEJM198612253152606","https://dx.doi.org/10.1016/j.mrrev.2008.03.002","//doi.org/10.1016/j.mrrev.2008.03.002","https://dx.doi.org/10.1016/j.ccr.2012.02.022","//doi.org/10.1016/j.ccr.2012.02.022","//www.ncbi.nlm.nih.gov/pubmed/22439926","https://dx.doi.org/10.1016/j.yexcr.2010.04.032","//doi.org/10.1016/j.yexcr.2010.04.032","https://dx.doi.org/10.1016/j.bbadis.2012.10.013","//doi.org/10.1016/j.bbadis.2012.10.013","https://dx.doi.org/10.1016/j.ccr.2011.01.020","//doi.org/10.1016/j.ccr.2011.01.020","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3060401","//www.ncbi.nlm.nih.gov/pubmed/21316604","https://dx.doi.org/10.1002/ijc.25612","//doi.org/10.1002/ijc.25612","https://dx.doi.org/10.1126/science.1203543","//doi.org/10.1126/science.1203543","//www.ncbi.nlm.nih.gov/pubmed/21436443","https://dx.doi.org/10.1002/jcb.21149","//doi.org/10.1002/jcb.21149","http://www.nature.com/nri/posters/mdscs/nri1005_mdscs_poster.pdf","https://dx.doi.org/10.1038/nature07205","//doi.org/10.1038/nature07205","//www.ncbi.nlm.nih.gov/pubmed/18650914","https://dx.doi.org/10.1016/j.jprot.2012.10.016","//doi.org/10.1016/j.jprot.2012.10.016","https://dx.doi.org/10.1158/0008-5472.CAN-07-0520","//doi.org/10.1158/0008-5472.CAN-07-0520","//www.ncbi.nlm.nih.gov/pubmed/17409393","https://dx.doi.org/10.1016/j.ccr.2005.02.013","//doi.org/10.1016/j.ccr.2005.02.013","//www.ncbi.nlm.nih.gov/pubmed/15766659","https://dx.doi.org/10.1016/j.cell.2010.03.014","//doi.org/10.1016/j.cell.2010.03.014","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4994190","//www.ncbi.nlm.nih.gov/pubmed/20371344","http://www.jleukbio.org/content/86/5/1065","//doi.org/10.1189/jlb.0609385","https://dx.doi.org/10.1182/blood-2005-01-0428","//doi.org/10.1182/blood-2005-01-0428","//www.ncbi.nlm.nih.gov/pubmed/16269622","https://dx.doi.org/10.3109/10428194.2010.529204","//doi.org/10.3109/10428194.2010.529204","https://dx.doi.org/10.1007/s12032-010-9638-5","//doi.org/10.1007/s12032-010-9638-5","https://dx.doi.org/10.1186/1476-4598-10-117","//doi.org/10.1186/1476-4598-10-117","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3190352","//www.ncbi.nlm.nih.gov/pubmed/21939504","https://www.nature.com/articles/nrc.2016.52","//doi.org/10.1038/nrc.2016.52","//www.ncbi.nlm.nih.gov/pubmed/27282249","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4852857","//doi.org/10.1038/nm.3909","//doi.org/10.1038/nrc.2016.54","//doi.org/10.1002/cncr.29100","//doi.org/10.18632/oncotarget.3283","//doi.org/10.1073/pnas.1320753111","//doi.org/10.1016/j.celrep.2017.11.052","//doi.org/10.1038/nature14282","//doi.org/10.1126/science.aal5081","//doi.org/10.1073/pnas.1424927112","//doi.org/10.1038/nature16140","//doi.org/10.1073/pnas.1015855107","//doi.org/10.1038/nature14407","//doi.org/10.1016/j.ccr.2011.08.012","//doi.org/10.1016/j.ccr.2009.06.017","//doi.org/10.1158/2326-6066.CIR-16-0297","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3578602","//doi.org/10.1016/j.yasu.2011.04.003","//www.ncbi.nlm.nih.gov/pubmed/21954698","https://dx.doi.org/10.1016/j.bcmd.2005.03.003","//doi.org/10.1016/j.bcmd.2005.03.003","https://dx.doi.org/10.1146/annurev.pathol.1.110304.100224","//doi.org/10.1146/annurev.pathol.1.110304.100224","https://dx.doi.org/10.1038/ncb1658","//doi.org/10.1038/ncb1658","//www.ncbi.nlm.nih.gov/pubmed/18037882","https://dx.doi.org/10.1002/jcp.10142","//doi.org/10.1002/jcp.10142","//www.ncbi.nlm.nih.gov/pmc/articles/PMC44705","//doi.org/10.1073/pnas.91.19.8856","//www.ncbi.nlm.nih.gov/pubmed/7522323","https://dx.doi.org/10.1016/S0959-437X(99)00043-X","//doi.org/10.1016/S0959-437X(99)00043-X","http://iopscience.iop.org/0031-9155/45/6/317/pdf/m00617.pdf","//doi.org/10.1088/0031-9155/45/6/317","https://dx.doi.org/10.1016/j.cell.2009.10.027","//doi.org/10.1016/j.cell.2009.10.027","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2788004","//www.ncbi.nlm.nih.gov/pubmed/19931152","//www.ncbi.nlm.nih.gov/pmc/articles/PMC4405035","//doi.org/10.1111/j.1365-2141.2011.08794.x","//www.ncbi.nlm.nih.gov/pubmed/21749361","https://dx.doi.org/10.1016/S0378-5173(96)04674-1","//doi.org/10.1016/S0378-5173(96)04674-1","https://dx.doi.org/10.1021/ja302743g","//doi.org/10.1021/ja302743g","//www.ncbi.nlm.nih.gov/pubmed/22827162","https://dx.doi.org/doi:10.4155/tde.12.127","//doi.org/10.4155/tde.12.127","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3584330","https://dx.doi.org/10.1177/1947601912466556","//doi.org/10.1177/1947601912466556","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3527984"],"sections":[{"toclevel":1,"level":"2","line":"History","number":"1","index":"1","fromtitle":"Tumor_microenvironment","byteoffset":2158,"anchor":"History"},{"toclevel":1,"level":"2","line":"Vasculature","number":"2","index":"2","fromtitle":"Tumor_microenvironment","byteoffset":5321,"anchor":"Vasculature"},{"toclevel":2,"level":"3","line":"Enhanced permeability and retention effect","number":"2.1","index":"3","fromtitle":"Tumor_microenvironment","byteoffset":6062,"anchor":"Enhanced_permeability_and_retention_effect"},{"toclevel":2,"level":"3","line":"Hypoxia","number":"2.2","index":"4","fromtitle":"Tumor_microenvironment","byteoffset":7492,"anchor":"Hypoxia"},{"toclevel":1,"level":"2","line":"Reactive stromal cells","number":"3","index":"5","fromtitle":"Tumor_microenvironment","byteoffset":11777,"anchor":"Reactive_stromal_cells"},{"toclevel":2,"level":"3","line":"Carcinoma associated fibroblasts","number":"3.1","index":"6","fromtitle":"Tumor_microenvironment","byteoffset":12925,"anchor":"Carcinoma_associated_fibroblasts"},{"toclevel":2,"level":"3","line":"Myeloid-derived suppressor cells and tumor associated macrophages","number":"3.2","index":"7","fromtitle":"Tumor_microenvironment","byteoffset":18118,"anchor":"Myeloid-derived_suppressor_cells_and_tumor_associated_macrophages"},{"toclevel":2,"level":"3","line":"Neutrophils","number":"3.3","index":"8","fromtitle":"Tumor_microenvironment","byteoffset":24663,"anchor":"Neutrophils"},{"toclevel":2,"level":"3","line":"Tumor infiltrating lymphocytes","number":"3.4","index":"9","fromtitle":"Tumor_microenvironment","byteoffset":36075,"anchor":"Tumor_infiltrating_lymphocytes"},{"toclevel":2,"level":"3","line":"Extracellular matrix remodeling","number":"3.5","index":"10","fromtitle":"Tumor_microenvironment","byteoffset":37809,"anchor":"Extracellular_matrix_remodeling"},{"toclevel":2,"level":"3","line":"Relation to T cells","number":"3.6","index":"11","fromtitle":"Tumor_microenvironment","byteoffset":43432,"anchor":"Relation_to_T_cells"},{"toclevel":3,"level":"4","line":"Reproduction","number":"3.6.1","index":"12","fromtitle":"Tumor_microenvironment","byteoffset":46466,"anchor":"Reproduction"},{"toclevel":3,"level":"4","line":"Apoptosis","number":"3.6.2","index":"13","fromtitle":"Tumor_microenvironment","byteoffset":50018,"anchor":"Apoptosis"},{"toclevel":3,"level":"4","line":"TAMs and MDSCs","number":"3.6.3","index":"14","fromtitle":"Tumor_microenvironment","byteoffset":50359,"anchor":"TAMs_and_MDSCs"},{"toclevel":3,"level":"4","line":"Spatial distribution","number":"3.6.4","index":"15","fromtitle":"Tumor_microenvironment","byteoffset":52246,"anchor":"Spatial_distribution"},{"toclevel":1,"level":"2","line":"Clinical implications","number":"4","index":"16","fromtitle":"Tumor_microenvironment","byteoffset":53770,"anchor":"Clinical_implications"},{"toclevel":2,"level":"3","line":"Drug development","number":"4.1","index":"17","fromtitle":"Tumor_microenvironment","byteoffset":53799,"anchor":"Drug_development"},{"toclevel":2,"level":"3","line":"Therapies","number":"4.2","index":"18","fromtitle":"Tumor_microenvironment","byteoffset":57686,"anchor":"Therapies"},{"toclevel":3,"level":"4","line":"Antibodies","number":"4.2.1","index":"19","fromtitle":"Tumor_microenvironment","byteoffset":57705,"anchor":"Antibodies"},{"toclevel":3,"level":"4","line":"Kinase inhibitors","number":"4.2.2","index":"20","fromtitle":"Tumor_microenvironment","byteoffset":58689,"anchor":"Kinase_inhibitors"},{"toclevel":3,"level":"4","line":"Liposomes","number":"4.2.3","index":"21","fromtitle":"Tumor_microenvironment","byteoffset":60110,"anchor":"Liposomes"},{"toclevel":1,"level":"2","line":"See also","number":"5","index":"22","fromtitle":"Tumor_microenvironment","byteoffset":60923,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"6","index":"23","fromtitle":"Tumor_microenvironment","byteoffset":60978,"anchor":"References"}],"parsewarnings":[],"displaytitle":"Tumor microenvironment","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q17164848"}]}}